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Abstract 
 
Celiac disease (CD) is characterized by an abnormal immune response that affects the small 
intestine of humans. While the cause and origin of the disease is unknown, the onset of the 
pathology is clearly associated with ingestion of wheat gluten, barley and rye, and 
susceptibility is strongly associated with certain human leukocyte antigen (HLA) molecules. 
More than 90% of the patients express HLA-DQ2.5 and most of the remaining express HLA-
DQ8. Furthermore, gluten-specific CD4+ T cells are mainly reactive to either of two 
immunodominant gluten peptides, glia-α1a or glia-α2, in the context of HLA-DQ2.5. The 
ability to detect and characterize this dominant peptide-major histocompatibility complex 
(pMHC) presentation on cells would allow for studies of cause and origin of the disease. The 
aim of this thesis has therefore been to develop a detection reagent potentially serving this 
purpose. The T cell receptor (TCR) has evolved to recognize pMHC complexes specifically 
and thus represents the ideal agent for their targeting. In order to employ TCRs as trackers of 
antigen presentation, however, the affinity has to be improved.  
 
As starting point, a stabilized single chain TCR (scTCR) composed of the variable domains of 
a HLA-DQ2.5-glia-α1a specific TCR was displayed on filamentous phage as a fusion to the 
phage coat protein pIX. The complementarity determining region (CDR)3 loops of the two 
variable domains were then randomized to created phage libraries. Furthermore, the resulting 
phage libraries were selected on recombinant HLA-DQ2.5-glia-α1a, through four rounds, to 
enrich for pMHC specific clones. Since a naïve single chain fragment variable (scFv) phage 
library had been panned against the same target in the laboratory, the selection was 
continuously monitored for presences of scFv phage contamination as well as for scTCR 
clones using PCR. scTCR phage was detected throughout the selection rounds, and as of the 
second round, scFv phage was detected in some of the phage libraries. In the third and second 
selection rounds, the phage libraries were pre-selected on protein L (pL) to counteract scFv 
phage propagation. 
 
Following selection, the phage libraries were analyzed in ELISA for binding to HLA-DQ2.5-
glia-α1a. When phage packaging was performed with M13K07 helper phage rescue, 14 of 22 
libraries showed reactivity. Subsequent single clone phage screening did not identify any 
binders and sequencing proved that a substantial part of the library comprised scFv clones. 
 9 
Further investigation revealed that the scFv phage was inefficiently produced upon 
DeltaPhage rescue. This was exploited to knock down the ELISA signal caused by the scFv 
clone. Indeed, when phage library rescue was performed with the DeltaPhage, only three of 
the 22 libraries showed reactivity. Single clone phage screening of these libraries identified 
two candidate clones, which turned out to be scFv clones after all.  
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1. Introduction 
1.1 Phage display technology 
1.1.1 Phage display 
 
Phage display was first described by Smith [4] and has proven to be a powerful method for 
selection of peptides and folded domains with desired binding specificities [5]. Phage display 
is a term that translates into display of foreign peptides or polypeptides on the surface of a 
phage particle. The filamentous phage M13 consists of five structural proteins that coat a 
single-stranded DNA (ssDNA) molecule. The major coat protein pVIII is the most abundant, 
covering the length of the phage particle. Hence, the number of units of pVIII in a virion is 
dependent on genome size. The phage particle is capped at one end by 3-5 copies of the minor 
coat proteins pIII and pVI, and at the other end by pVII and pIX (Figure 1).	   
 
 
 
Figure 1: Schematic presentation of the filamentous phage. Five structural proteins coat the ssDNA 
genome. The figure is adapted from [6]. 
 
The filamentous phage can infect Escherichia coli (E. coli) bacteria that express surface F 
pili. Phage infection occurs through binding of the pIII on the phage to the F pilus on the 
bacteria and translocation through the TolA receptor complex in the bacterial membrane [7, 
8]. The filamentous phages replicate and assemble with a non-lytic life cycle [9]. All capsid 
proteins are located in the inner membrane prior to viron assembly [10], but only pIII, pVI 
and pVIII are synthesized as precursors with classical N-terminal signal sequences. pVII and 
pIX appear to be synthesized without such signal peptides and their mechanism of 
translocation to the membrane is still incompletely understood, but at least pIX may depend 
on the YidC translocon as recently described [11-13].  
Phage display can be accomplished by e.g. subcloning the gene encoding a protein of interest 
(POI) in-frame to the gene encoding a capsid protein. The POI displayed on the phage is thus 
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encoded in the ssDNA genome harbored by the same phage particle. This provides a physical 
link between the phenotype and genotype, which is a key feature of the selection platform. 
pIII and pVIII display are referred to as the conventional phage display formats, being the 
most commonly used display capsids. However, POI have been fused to and displayed on all 
five capsid proteins and the use of pVII and pIX display have lately been shown to be 
particularly efficient in affinity selection [6].  
 
A phage display library is a collection of billions of unique clones that encode and display 
different fusion proteins. Such libraries may be composed of peptides, protein variants and 
gene fragment- or cDNA-encoded proteins and may hold more	  than	  1012 individual members 
[14]. Library members exhibiting desired phenotypes are selected and enriched for in a 
selection process. Selection is carried out by incubating the phage library with a target of 
interest that is often immobilized on a solid phase, removal of nonbinding phages by washing, 
and release of the binding phages by changing the pH, competitive elution or by protease 
digestion. The eluted phages are used to infect E. coli for amplification, prior to the next 
round of selection. This process is normally repeated for several rounds, before individual 
clones are analyzed, and this is usually required to isolate high-affinity binders [9].  
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Figure 2: General overview of phage display selection. Library phages are incubated with target (A). 
Nonbinding phages are washed away (B), and binding phages are eluted (C). Eluted phages are 
introduced into E. coli for amplification on solid (D) and/or in liquid growth medium (E). Individual 
clones are available for analysis after each selection round (F). The figure is adapted from [15]. 
 
1.1.2 Display formats 
 
POI-coat protein fusions can be encoded in a phage vector or in a phagemid vector [9]. Phage 
vectors are derived from the genome of filamentous phage and encode all the proteins 
required for replication and virion assembly. Classical phage vector system yields high 
valence display of the POI, because the fusion protein will be the only source available of the 
coat protein to which the POI-encoding gene is fused [16]. 
  
Phagemids are plasmids that usually encode for one POI-capsid fusion, and in addition carry 
two origins of replication, one phage-derived and one the plasmid-derived, and a packaging 
signal of filamentous phage [17]. Since the phagemid contain the gene encoding for one coat 
protein only, a helper phage is used to provide the genetic material encoding the remaining 
coat proteins and also other proteins required for phage production. This process, by which 
phage production is achieved by helper phage supplementation, is called “phage rescue”. Both 
phagemid-carrying phages and helper phage genome-carrying phages are produced by phage 
rescue [9]. In this system, the display coat protein is provided by two sources and both 
phagemid-derived fusion protein and wt coat protein encoded by the helper phage genome, 
are incorporated into the rescued virions yielding low valence display. 
 13 
There are advantages and drawbacks with both systems. The phage vector system always 
ensures genotype-phenotype coupling, while in the phagemid vector system phage displaying 
fusion proteins will have one of two genotypes. This may lead to loss of selected clones 
during selection if the phagemid is not preferentially packaged upon phage rescue [9]. The 
phagemid vector is more efficiently transformed due to the small size compared with phage 
vectors [17], and this is especially important when wanting to generate high diversity 
libraries. Whereas the phage genome is very compact and sensitive to genetic alternations, the 
phagemids are genetically more stable and often constructed to facilitate quick exchange of 
the POI. 
 
Low valence display is favorable for applications such as high affinity selection where high 
monomeric affinity is the aim. However, when standard phagemid systems are used, only a 
few percent of phages actually carry the fusion protein [18]. Hence, when highly diverse 
libraries are used in the initial round of selection, and each clone is present in limited numbers 
(<1000), the risk of losing desired clones at random is high. High valence display is more 
efficient in retrieving specific clones. This has been demonstrated by comparing selections 
conducted with phage libraries and phagemid libraries, where a greater number of 
specificities were retrieved from the phage libraries [19].  
 
High valence display using phagemid vectors can be achieve by using modified helper phages 
that fail to encode a functional version of the display coat protein. Such systems have been 
described for both pIII and pIX coat proteins [20, 21]. By exploiting this, initial rounds of 
selection may be performed with increased efficiency in retrieval of specific clones. By 
switching to a classical helper phage, subsequent selection rounds may be performed with low 
valence display to select for affinity among the specific binders isolated in the initial 
selection. In this way beneficial properties of the phage vector and phagemid vector systems 
are combined. 
 
1.1.3 Applications of phage display  
 
Many different proteins have been displayed on the phage and the technology has been used 
for various applications, including epitope mapping of antibodies [22], screening for receptor 
ligands [23], in vitro evolution of proteins [24], discovery of enzyme substrates [25], analysis 
of protein-protein interactions [26] and a lot more. Isolation of monoclonal antibodies from 
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large antibody libraries is by far the most successful use of phage display. The fragment 
antigen binding (Fab) and the scFv formats are the two most popular formats for antibody 
display. The scFv consist of the variable domains of the heavy and light chains that are 
connected by a flexible peptide linker, and thus comprises the antigen binding site [27].  
 
1.2 Antigen binding receptors of adaptive immunity 
1.2.1 Lymphocytes and their role in the immune system 
 
T lymphocytes (T cells) and B lymphocytes (B cells) are important components of the 
adaptive immune system. The antigen binding receptor of the B cells recognize structures on 
the surface of antigens, such as those secreted by or expressed on surface of pathogens. Naïve 
B cells express cell surface membrane-bound B cell receptors (BCRs). Upon exposure and 
BCR ligandation of antigen the B cell may proliferate and differentiate into memory cells or 
plasma cells that secrete antibodies, a soluble form of the BCR. The antibody molecule 
mediates its effect by neutralization or by engaging other immune cells. The cell surface 
TCRs of T cells recognize foreign antigen as peptides bound to MHC on the surface of 
antigen presenting cells (APCs). Two major T cell subsets exist, CD4+ and CD8+ T cells, 
which are different in the co-receptor they express, CD4 and CD8, respectively, and in their 
ligand binding properties. CD4+ T cells recognize endosome-derived antigenic peptides in 
complex with MHC class II molecules on professional APCs. CD8+ T cells recognize cytosol 
derived antigenic peptides in complex with MHC class I molecules, that are presented on 
nucleated cells. Upon activation, the naïve T cells proliferate and differentiate into effector 
and memory cells. The CD4+ T cells develop into T helper cells and the CD8+ T cells 
develop into cytotoxic T cells. In this thesis the main focus will be on the TCR. 
 
1.2.2 The TCR molecule 
 
The TCR molecule is a membrane-bound heterodimeric glycoprotein composed of two 
polypeptide chains, either α and β in αβ T cells or γ and δ in γδ T cells. The complete 
structure of a heterodimeric T cell receptor was first proposed in 1984 [28]. Each chain 
consists of an intracellular segment, a single transmembrane α-helix and two extracellular 
domains, one constant (C) and one variable (V) located proximal and distal to the membrane, 
respectively. An inter-chain disulfide bridge in the membrane proximal part of the molecule 
covalently couples the two chains [28]. The TCR molecule resembles the fragment antigen 
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binding (Fab) part of an antibody and, along with antibodies and MHC molecules it belongs 
to the immunoglobulin superfamily. The extracellular domains of the TCR adopt an 
immunoglobulin (Ig) fold comprising two closely packed anti-parallel β-sheets connected by 
a conserved disulfide bridge [29, 30]. The β-strands are connected by flexible loops, and in 
the V domains, three of these loops, are particularly diverse and position to contact the 
antigen. The highly diverse loops are called hypervariable loops, or more commonly the 
CDRs, as the surface they form is complementary to the antigen they bind.  	  
	  
 
1.2.3 Antigen recognition by TCRs 	  
The TCR is restricted to recognize its antigen presented in the context of a MHC molecule 
[31]. Since the first crystal structure of intact TCR bound to pMHC was determined in 1996 
[32, 33], dozens of unique TCR-pMHC complexes have been reported. These crystallographic 
data have given insight into the interaction between the TCR and pMHC and some general 
features are observed. The TCR bind in a roughly diagonal orientation relative to the long axis 
of the MHC peptide-binding groove, with the Vα and Vβ domain positioned above the N- and 
C-terminal halves of the peptide, respectively. This generally places the germline-encoded 
CDR1 and CDR2 loops in contact with conserved helical residues of the MHC, while the 
CDR3 loops, which exhibit the greatest degree of sequence diversity, primarily contact the 
peptide [2]. Kinetic analyses suggest that the TCR first make the appropriate contacts with the 
MHC to orient itself into the correct position for recognition of the peptide [34]. Thus, TCR-
pMHC specificity is ensured by a restricted docking mode that involves TCR recognition of 
!
Figure 3: Schematic presentation of a 
αβ TCR. The TCR is composed of two 
transmembrane glycoprotein chains, α 
and β. The figure is adapted from 
Immunobiology 8th edition [3]. 
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both the peptide and the MHC molecule. Structural comparisons of TCRs in free and antigen 
bound forms have revealed that conformational changes, mainly in the CDR3 loop region, 
occur upon binding [35]. Flexibility of the contact surface might enable the TCR to adapt to 
various pMHC ligands, resulting in some degree of promiscuity [36].  
 
 
 
Like for antibodies, TCR diversity is created through a rearrangement of germline gene 
segments that also involve deletion and insertion of random nucleotides, to generate a huge 
collection of specificities against potential antigens. During development in the thymus, T 
cells whose receptors recognize self-peptides in the context of self MHC too strongly are 
eliminated [37]. Unlike antibodies, TCRs do not undergo somatic hypermutation and affinity 
maturation upon activation to produce high affinity clones. Consequently, native monovalent 
αβ TCRs have low affinities. The intrinsic affinity of TCRs for ligand has been measured, 
mostly by SPR-based approaches, to be in the range of 1-100 μM, and relatively slow 
association and very fast dissociation kinetics characterize the interaction [38, 39]. This is in 
Figure 4: (Left) Structure of a TCR-pMHC 
class II complex. The CDR loops of the 
TCR are indicated in color: CDR1β cyan, 
CDR2β pink, CDR3β yellow, CDR1α dark 
blue, CDR2α magenta and CDR3α green. 
The β chain HV4 loop is shown in orange. 
The red line is the bound peptide. (Above) 
Footprint of a TCR/pMHC class II 
complex. The top surface of a MHC is 
show and the TCR contact area is colored 
by the CDR loops. The figure to the left 
was prepared using PyMol v1.3 
(Schrodinger LLC, NY, USA) from PBD 
ID: 1fyt, and the above figure was adapted 
from [2]. 
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contrast to the kinetics reported for antibody-antigen interactions. Weak affinity has proved to 
apply for many interactions occurring between adjacent lipid bilayers of interacting cells. 
While soluble antibodies and their respective ligands may be locally present at low 
concentration and thus require affinities in the nanomolar range, high local concentration of 
interacting membrane bound molecules on opposing lipid bilayers may allow for intrinsic 
affinities several orders of magnitude lower, yet concomitantly exhibit very strong 2D 
affinities, as in the case of the TCR-pMHC interaction [38, 40]. 	  
 
1.3 TCR engineering 
 
Recombinant TCR molecules have great potential as diagnostic and therapeutic agents as well 
as detection reagents in basic research. The TCR has evolved to recognize pMHC complexes 
specifically, and may therefore be a better candidate than the antibody in generation of 
specific ligands towards this class of antigen. However, there are two main issues that have 
hindered rapid development of such ligands, TCRs are hard to produce in soluble form and 
have low intrinsic affinity for its antigen [41].  
 
1.3.1 Soluble TCRs 
 
Expression of antibody fragments in E. coli, as well as in eukaryotic systems, has been highly 
successful [42]. Despite the resemblance in structure, soluble TCRs are generally much more 
unstable and hard to produce compared to antibodies. Antibody fragments are also readily 
expressed as fusion proteins to coat proteins of yeast and phage, while display of TCR has 
been more challenging [42]. The main reason seems to be the interface between the V and C 
domains, which is more extensive in TCRs than in antibodies [42]. When TCRs are expressed 
in soluble form, and in particular as scTCRs, hydrophobic patches are displayed which 
promote aggregation [43].  
 
Many different strategies have been pursued in order to produce TCRs in a soluble form and 
as fusions to the coat proteins of yeast and phage. This includes the use of scTCR format [44], 
co-expression of chaperones i.e. Skp and FkpA [45-47] and introduction of a inter-chain 
disulfide bond to improve stability and folding [48]. Introductions of stabilizing mutations 
have also been important for increased expression yield and display level on yeast and phage 
[49, 50].	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1.3.2 High affinity TCRs 
 
The affinities of native TCRs for its cognate ligand falls within the range of 10-6 M to 10-4 M 
[39], with a binding half life of only a few seconds [38]. This range of affinities is too low to 
enable stable cell-surface adhesion of monovalent soluble TCRs [41]. One approach to 
increase the TCRs relative affinity is to produce multimeric proteins. MHC tetramer 
technology is a well-established method for making high avidity, multimeric pMHCs [51-54] 
and has also been successful for TCRs [55, 56]. These multimeric TCRs were used to stain 
APCs pulsed with peptide in vitro, which the monovalent form of the TCR could not [55, 56]. 
Multimeric TCRs may serve as a general approach to generate diagnostic and research tools, 
where immunogenicity is not a critical issue [55]. However, a potential problem with 
multivalent TCR complexes is that avidity binding might not occur at low cell-surface antigen 
densities observed physiologically [57]. 
 
The intrinsic affinity of TCRs can be increase by affinity maturation, which typically involved 
three steps: (i) introduction of diversity in the V genes of the TCR, thus creating a library of 
gene variants, (ii) selection of the higher affinity from the low affinity variants and (iii) 
screening to identify TCR variants featuring the desired affinity [58]. In this approach, the 
power of Darwinian selection is harnessed to evolve proteins with properties not found in 
nature [59]. Affinity maturation can be mediated by yeast and phage display technology and 
has been successful in obtaining high affinity TCRs capable of directly detecting pMHC 
complexes of APCs in soluble monomeric forms [24, 60, 61].  
 
By using yeast surface display, Holler et al. [60] and Shusta et al. [62] produced variants of 
the 2C TCR by mutating the CDR3α loop, and selected mutants with 100-fold increase in 
affinity, up to 9 nM. Wild type TCRs are not stable on yeast and thus prior to affinity 
selection, mutagenesis and stability selection is required to allow surface display on yeast 
[50]. Li et al. [24] was the first to report successful generation of high affinity TCRs using 
directed evolution and phage display. The selected variants contained mutations in the CDR3 
loops primarily, which resulted in nanomolar and picomolar affinities and increased binding 
half life from 7 s to more than 15 h. The high affinity TCRs could bind to pMHC complexes 
on the surface of APCs, and showed no detectable cross-reactivity [24]. Furthermore, Dunn et 
al. [61] have been successful in selection of high-affinity TCR variants from libraries 
generated by mutations in the germ line encoded CDRs (CDR2s).  
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Thus, it does not appear to be an intrinsic affinity threshold preventing TCRs to be artificially 
engineered to obtain substantially higher monomeric affinities in solution than what is found 
in nature. As the peptide fine-specificity of such engineered TCRs is retained, naturally 
occurring TCRs therefore represent a very attractive starting point for affinity maturation to 
obtain highly sensitive pMHC-specific targeting molecules for a variety of application both in 
basic research and for therapy [63-66]. 
 
1.4 Celiac disease 
 
CD is an inflammatory condition of the small intestine that affects approximately 1% of the 
population of most western countries [67, 68]. The disease is caused by an inappropriate 
immune response to dietary wheat gluten and similar proteins in barley and rye and leads to 
destruction of the small intestine epithelium. Selective tissue destruction is one of several key 
features that CD shares with autoimmune disorders. More strikingly is the presence of 
disease-specific, gluten-dependent autoantibodies specific for the enzyme tissue 
transglutaminase 2 (TG2). Furthermore, a strong association with certain HLA class II 
molecules is seen with more than 90% of the patients expressing HLA-DQ2.5 and the 
remainder expressing HLA-DQ8 [69, 70]. These particular HLA molecules have a unique 
ability to bind proline and glutamine rich gluten peptides that have been deaminated by TG2 
[71, 72].  
 
The importance of genes in CD is supported by familial clustering and by high concordance 
in twins [73]. Most people that have the disease-associated HLA class II molecules do not 
have CD, and HLA is thus considered a necessary but not a sufficient factor for disease 
development [74]. Genome-wide association studies have lead to the discovery of several 
non-HLA genes as susceptibility factors, many of which are related to the immune response 
[75].  
 
The strong HLA class II association suggests that T cells are important for the pathogenesis. 
Upon ingestion of gluten one can see an abnormal influx of CD4+ T cells that recognize 
gluten-derived peptides in the context of HLA-DQ2.5 or HLA-DQ8 presented by APCs [76]. 
It is believed that these T cells orchestrate the immune response that leads to the destruction 
of the epithelium through the release of proinflammatory cytokines such as interferon-γ [77]. 
Most of the HLA-DQ2.5 restricted CD4+ T cells are reactive to either of two 
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immunodominant gluten peptides, glia-α1a and glia-α2 [78]. These are epitopes found within 
a 33mer peptide fragment that remains intact after gastrointestinal digestion of certain wheat 
proteins known as α-gliadins [79]. The high proline content of gluten proteins makes them 
resistant to digestion by gastrointestinal proteases. This results in long antigenic peptide 
fragments that pass through the epithelial barrier of the intestine where TG2 awaits [74, 79]. 
 
 
 
 
 
 
1.4.1 APCs in the small intestine 
 
Dendritic cells (DCs), macrophages and B cells are professional APCs that initiates adaptive 
immune responses, by presenting antigenic peptides bound to cell surface MHC class II 
molecules. Distinct subsets of APCs in the intestine have different origin and functions. 
Hence, some migrate to the lymph nodes to activate naïve T cells into becoming effector or 
regulatory T cells, while others stimulate activated T cells locally in the mucosa.  
 
Figure 5: Schematic presentation of 
key features in the pathogenesis of 
CD. Gluten peptides cross the 
intestinal barrier into the lamina 
propria where they serve as 
substrates for TG2. Deamination of 
glutamine residues into glutamic 
acid creates antigens that are better 
suited to bind the disease-associated 
HLA molecules. Glutamate serves as 
an anchor residue at positions P4, 
P6 and P7 for peptides binding to 
HLA-DQ2.5. Antibodies recognizing 
gluten and TG2 are generated. The 
figure is adapted from [1]. 
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In the duodenum, the first part of the human small intestine, macrophages and DCs constitute 
the main population of APCs. These are mainly derived from monocytes and classical 
myeloid DCs precursors cells [80]. The HLA-DQ expressing APCs have been studied by Raki 
and Beitnes et al, and in the intestinal mucosa about 80% are CD163+ macrophages and 20% 
are CD11c+ DCs [81]. CD163 and CD11c are classical markers for macrophages and DC, 
respectively. The CD11c+ DC population can further be subclassified into cells expressing 
CD163, CD103 or CD1c. The CD11c+CD163+ DCs thus have an intermediate phenotype, 
expressing both the macrophage and DC markers, and represent roughly 7% of all HLA-DQ+ 
APCs [82]. 
 
The densities of the different subpopulations are characteristically altered in the active celiac 
lesion. The density of intermediary CD163+CD11c+ DCs increase, while the density of 
CD103+CD11c+ DCs, CD1c+CD11c+ DCs and CD163+CD11c- macrophages decreases 
[82]. The decreased intestinal density of CD103+CD11c+ DCs in CD has been hypothesized 
to at least partly be due to migration of these cells to lymph nodes. It has been demonstrated 
that equivalent CD103+CD11c+ DCs in mice are able to migrate to the draining lymph node 
and human CD103+CD11c+ DCs are readily detected in mesenteric lymph nodes [83, 84]. 
While the DC subgroup may migrate to the draining lymph node, present gluten peptides, and 
activate gluten-specific naïve T cells, the intermediate DC subgroup, which is increased in 
density in the active celiac lesion, may be responsible for driving intestinal pathology by 
activation gluten-specific memory T cells [85]. CD11c+ DCs, isolated from gluten-challenged 
mucosal biopsies, were found to be effective presenters of gluten peptides to gluten-reactive T 
cell clones [81]. Furthermore, the increased density of intermediate DCs precedes the typical 
changes in mucosal architecture, indicating that this DC subset may be involved in disease 
initiation [85]. 
 
The exact contribution of the different subgroups identified cannot be fully elucidated without 
including a DQ2.5-gluten peptide-specific detection reagent to complement previous studies. 
Moreover, the DQ2.2 vs. DQ2.5 discrepancy in CD predisposition has been suggested to rely 
on a spatial and temporal gradient in the tissue resulting in different peptide presentation 
ability to relevant T cells at activation sites [86]. Thus, analyzing gluten peptide presentation 
by the distinct APC subgroups, both where presentation occurs and how much is presented 
will be important for understanding CD.  
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1.4.2 TCRs in CD  
 
A public T cell response, in which multiple individuals share identical or close to identical 
TCR repertories towards the same antigenic epitope, has been observed in a variety of 
immune responses [87], including towards DQ2.5-glia-α2 among CD patients. Sequencing of 
the TCR genes from dozens of gluten specific T cell clones, isolated from CD patients, have 
provided insight into the repertoire [88, 89].  
 
The DQ2.5-glia-α2 reactive T cells show a biased usage of the Vβ6.7 chain, encoded by 
TCRβ variable (TRBV) 7-2 gene segment. Furthermore, most of these TCRs express a non-
germline encoded arginine residue in the CDR3β loop, which has been shown to be critical 
for T cell recognition [88]. Moreover, the TRBV7-2 encoded β-chain show preferred pairing 
to a TCRα chain, encoded by the human TCRα variable (TRAV) 26-1 gene segment [89].  
 
Very recently, the crystal structures of three distinct TCRs in complex with DQ2.5-glia-α2 
and one TCR in complex with DQ2.5-glia-α1a were reported. Among other findings, the 
CDR3β loop of the DQ2.5-glia-α2 specific TCRs was found to sit above the peptide, and the 
main contributor to the CDR3β-HLA-DQ2-mediated interaction was the conserved arginine, 
which arched down into the antigen binding cleft and interacted with the peptide [90]. The 
Vβ6.7 chain footprint on HLA-DQ2 was maintained in the three crystals, suggesting an 
important role in mediating docking.  
 
Compared to DQ2.5-glia-α2 specific TCRs, a smaller degree of biased TCR usage against 
DQ2.5-glia-α1a was observed [90]. However, TCRs of DQ2.5-glia-α1a reactive T cells have 
also been found to carry the TRBV7-2 gene segment (Qiao et al. unpublished). For the DQ8-
glia-α1 specific T cells, a biased usage of the TRBV9 gene segment, coupled with a preferred 
paring of the TRAV26-2 gene segment has been reported [91]. 
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2. Aim of the thesis 
 
The strong disease association of HLA-DQ2.5 indicates an important role of antigen 
presentation and T cell activation in CD. The TCR has evolved to recognized pMHC 
complexes specifically and thus represents the ideal ligand for their targeting. However, the 
low affinity of the TCR for pMHC prevents its direct use as trackers of peptide presentation.  
 
The main objective was to develop an artificial high affinity HLA-DQ2.5-glia-α1a specific 
reagent, by use of phage display engineering, based on a naturally occurring TCR derived 
from a CD lesion.  
 
The Vβ6.7+ TCR 380 specific for DQ2.5-glia-α1a was chosen as the starting point. As 
describe by Molberg et al. [92] the T cell expressing TCR 380 was isolated from a CD patient 
using DQ2.5-glia-α1a tetramers. The TCR V genes were cloned and employed to construct 
the scTCR s380 prior to this thesis (Løset et al., unpublished). Moreover, the wt Vα-Vβ 
interface was engineered to reconstruct an optimal domain pairing resulting in both improved 
soluble expression and display propensity on pIX (Neuman and Høydahl et al., unpublished). 
The stabilized variant was named s380 and is described herein. In order to affinity mature 
scTCR s380, it was displayed on filamentous phage as a fusion to the phage coat protein pIX. 
Phage libraries were generated by individual randomization of the CDR3α and CDR3β loops 
prior to this thesis (Høydahl et al. unpublished, supplementary 1).  
 
The aim of this thesis was to perform the scTCR s380 phage library selection on DQ2.5-glia-
α1a and to identify scTCR s380 clones with improved affinity.   
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3. Materials and methods 
3.1 General material 
3.1.1 Bacteria 
 
The E. coli XL1-blue strain (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB 
lacIqZΔM15	  Tn10	  (Tetr)]	   (Stratagene,	  CA,	  USA)	  was used for titration. The E. coli SS320	  strain	   ([F\'proAB+lacIqlacZΔM15	   Tn10	   (tetr)]	   hsdR	   mcrB	   araD139	   Δ(araABC-­‐leu)7679ΔlacX74	  galUgalK	  rpsL	  thi	  (Lucigen,	  WI,	  USA) was used for amplification of phage 
libraries in selection. The E. coli TOP10 F’ strain	   (F'[lacIq	   Tn10(tetR)]	   mcrA	   Δ(mrr-­‐hsdRMS-­‐mcrBC)	  φ80lacZΔM15	  ΔlacX74	  deoR	  nupG	  recA1	  araD139	  Δ(ara-­‐leu)7697	  galU	  galK	  rpsL(StrR)	  endA1	  λ-­‐	  (InvitrogenTM,	  CA,	  USA)	  	  was	  used for amplification of multivalent 
pIX phage. 
3.1.2 Plasmids 
 
For phage display on pIX the previously described pGALD9ΔLFN phagemid was used [6]. In 
addition to all the other components of pGALD9ΔL, it contains a FkpA cassette that is 
controlled by its native promoter [45]. The pGALD9ΔLFN phagemid encoding scTCR s380 
is illustrated in Figure 6. The scTCR is in a Vα-linker-Vβ format and is genetically fused N-
terminal to the pIX gene.	  
 
 
Figure 6: Schematic drawing of the pGALD9ΔLFN-scTCR s380 phagemid. The phagemid contain the 
following elements: a phage f1 packaging signal (f1), an ampicillin resistance-encoding gene, an 
origin of replication (ColE1), a lac promoter, a scTCR s380-encoding cassette fused to the pIX gene 
and a terminal signal, and a gene encoding the chaperone FkpA. 
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3.1.3 Helper phage  
 
Two different helper phages have been used; M13K07 purchased from Amersham Bioscience 
(Uppsala, Sweden) and DeltaPhage, which have been constructed in Sandlie lab. Both have 
been described previously in [93] and [21], respectively.  
3.1.4 Antibodies and additional reagents 
 
Mouse anti-M13 HRP monoclonal antibody was purchased from GE Healthcare Life Sciences 
(Uppsala, Sweden). Rabbit anti-mouse-IgG HRP antibody was purchased from Sigma-
Aldrich (St. Louis, MO, USA). The mouse anti-DQ2 monoclonal antibody 2.12.E11	  was	  a	  kind	   gift	   from	   Professor	   Ludvig	   M.	   Sollid. Recombinant protein L (pL) immunoglobulin 
binding protein and NeutrAvidin (NA) biotin binding protein were both purchased from 
Thermo scientific	   (Rockford,	   IL,	   USA). Synthetic oligonucleotide primers	  were	   purchased	  from	  Eurofins Genomics (Ebersberg, Germany). Recombinant DQ2.5 with glia-α1a	  or	  CLIP2	  peptide were kind gifts from Professor	   Ludvig	   M.	   Sollid, and have been produced and 
purified as described [94]. The peptide is coupled to the N-terminal of DQ2 β-chain through a 
15-residue linker [95].	  
 
3.2 Preparations for phage selection  
3.2.1 Production of helper phage 	  
E. coli XL1-Blue harboring either the M13K07 or the DeltaPhage genome was inoculated in 
2x YT supplemented with 50 µg/ml kanamycin (kan). The cultures were incubated with 
shaking at 220 rounds per minute (rpm) at 37°C overnight (ON) using INFORS HT thermal 
shaking incubator (VWR, Radnor, PA, USA). The following day supernatants were harvested 
by centrifugation at 3220xg/30min/4°C using Sorvall RC3R pluss centrifuge (VWR) and 
sterile filtered using 0.2 µm filters (Millipore, Billerica, MA, USA). Virion particles were 
precipitated by mixing the supernatant with 1/5 volume of PEG/NaCl (20% polyethylene 
glycol (PEG) 8000 (Sigma-Aldrich, Oslo, Norway) and 2.5 M NaCl), followed by incubation 
in ice-slurry for 3 hours. The precipitated phage was pelleted by centrifugation at 
3220xg/30min/4°C using the Sorvall centrifuge and the pellets were re-suspended in 1x PBS 
pH 7.4. To remove any remaining debris, the phage solutions were centrifuged at 
13000xg/5min/RT and the supernatants were transferred to new tubes and stored at 4°C. 
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3.2.2 Spot titration of phages 	  
Phage stocks rescued by the helper phages M13K07 or DeltaPhage were titrated by standard 
spot titration [96]. E. coli XL1-Blue was inoculated in 2x YT supplemented with 30 µg/ml 
tetracyclin (tet) and incubated with shaking at 200 rpm/37°C/ON using SI-600R incubator 
(Lab companion, Seoul, Korea). For each phage stock a dilution series was prepared in 
1xPBS pH 7.4 according to Table 1. 10 µl of each phage dilution was transferred to a 96-well 
microtiter plate (Corning Incorporated, NY, USA). The XL1-blue ON culture was 
reinoculated to A600nm 0.025 in 2x YT supplemented with 30 µg/ml tet and incubated with 
shaking at 220rpm/37°C until OD600nm 0.5 was reached. 190 µl of the XL1-blue culture was 
transferred to each phage dilution in the microtiter plate and was further incubated at 
200rpm/37°C/30min using Titramax 1000 (Heidolph, Schwabach, Germany). Volumes of 3 
µl of each preparation were spotted onto BA85/20 nitrocellulose membranes (Whatman, 
Dassel, Germany) that were laid on top of LB-agar dishes supplemented with either 100 
µg/ml ampicillin (amp) or 50 µg/ml kan. The dishes were incubated at 37°C/ON. The number 
of colony forming units (cfu)/ml was calculated using the formula (cfu x dilution-1 x 20 x 
1000)/3. Cfu/ml calculated from LA-amp dishes equals to the number of phagemid-carrying 
phage in the stock solution and cfu/ml calculated from the LA-kan dishes corresponds to the 
number of helper phage genome-carrying phage. 
 
Table 1: Overview of dilutions made in spot titration of phage 
Dilution Gradient 1x PBS Transfer 
A 10-2 495 µl 5 µl from stock 
B 10-4 495 µl 5 µl from A 
C 10-5 450 µl 50 µl from B 
D 10-6 450 µl 50 µl from C 
E 10-7 450 µl 50 µl from D 
F 10-8 450 µl 50 µl from E 
G 10-9 450 µl 50 µl from F 	  	  
3.3 Selection of phage libraries 
3.3.1 Pre-selection on pL 
 
MaxisorpTM immunotubes (Nunc, Roskilde, Denmark) were coated with 30 µg pL in 3 ml 
1xPBS and incubated ON/4°C. The immunotubes were blocked with 3 ml 1xPBS containing 
0.05% Tween 20 (Sigma, MO, USA) and 4% skim milk (AppliChem, Gatersleben, Germany) 
(PBSTM) for 30min/RT on a SB3 rotator (Stuart). Volumes of 100 µl phage library were 
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blocked under the same conditions in 3 ml PBSTM. Following blocking, the phage was 
transferred to the immunotubes and incubated for 1h/RT on a rotating wheel. 1 ml of the 
phage solution was channeled into the selection procedure described in 3.3.2. 	  
3.3.2 Selection  
 
Four rounds of selection were preformed. Prior to each round all components were incubated 
with blocking agent dissolved in 1xPBS supplemented with 0.05% Tween 20 (PBST) for 
minimum 30 minutes/RT. The blocking agent used was alternated each round between 4% 
skim milk and 2% bovine serum albumin (BSA) (Sigma). 
 
The Dynabeads MyOne Streptavidin T1 (InvitrogenTM) were washed and blocked prior to use. 
The beads were resuspended in the stock solution by vortexing for 30 seconds before the 
required volume was transferred to a 1.5ml eppendorf tube. The beads were washed twice by 
addition of 1 ml PBS, pH 7.4 and brief vortexing. By placing the tubes in a DynaMagTM 
magnet rack (Life technologiesTM, CA, USA) the beads accumulated on the tube wall and the 
solution could be removed. After blocking, the beads were observed in a light microscope 
(Nikon TMS, Japan) as single entities floating in the fluid. 
 
Selection was executed by incubating the phage with biotinylated pMHC target, starting with 
60 nM pMHC in R1 followed by 10x decrease per round, in 1 ml blocking solution for 1h/RT 
on a SB3 rotator (Stuart). The phage libraries were first incubated with biotinylated HLA-
DQ2.5-CLIP2 (referred to as negative selection) and the resulting phage-antigen complexes 
were captured onto streptavidin-magnetic beads by incubation for 30min/RT on a SB3 rotator 
(Stuart). The beads containing bound complexes were concentrated on the tube wall using the 
DynaMagTM magnet rack (Life technologies) and the supernatant was transferred to new 1.5 
ml tubes. Biotinylated HLA-DQ2.5-glia-α1a was added to the remaining phage in the 
supernatant and incubated (referred to as positive selection), before the resulting phage-
antigen complexes were captured onto beads. 
 
In the first round of selection, positive selection was directly followed by washing bead-
captured phage-antigen complexes; ten times with 1xPBST and then ten times with 1x PBS, 
with a brief vortex each time. 
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Starting from the second round of selection, positive selection was followed by addition of 
free soluble DQ2.5-glia-α1a in excess in two rounds. The beads were incubated with free 
antigen in 1ml blocking solution on a rotating wheel for 30 min, before the solution was 
removed like before and stored (later referred to as eluate 1, or E1). New free target was 
added in 1ml blocking solution and incubated on a rotating wheel for 60 min, followed by 
removal and storage of the solution (later referred to as eluate 2, or E2). Prior to the first and 
the second addition of soluble DQ2.5-glia-α1a, the beads were washed by the same procedure 
as described above, two times with 1xPBST and two times with 1xPBS. Sequential washing 
of the beads was performed after off-rate selection in the same way as in the first round of 
selection.  
 
Phage bound to the beads through interactions with biotinylated DQ2.5-glia-α1a were eluted 
by incubating the samples with 0.5 ml 100 mM TEA pH 11 (Sigma) at RT/20min. using a 
SB3 rotator (Stuart), followed by placement of the sample tubes in the magnet rack and 
transfer of the solution to 0.5 ml 1 M tris-HCl, pH 7.5 for neutralization (later referred to as 
eluate 3, or E3). 
 
3.3.3 Infection of E. coli SS320 with selection output and phagemid rescue 
 
Phage-containing solutions obtained during the selection procedure were used to infect log-
phase E. coli SS320 cultures that were estimated to comprise approx. 2.5x1010 cells. The 
cultures were incubated at 80rpm/37°C in SI-600R incubator (Lab companion) for 25 minutes 
after addition of the phage. The infected cells were pelleted by centrifugation at 
3220xg/15min/RT using Centrifuge 5810R (Eppendorf, Hamburg, Germany), carefully 
resuspended in 2 ml 2xYT-medium and plated onto large 24.5x 24.5 cm Bio-Assay Dishes 
(Nunc) containing LB-agar supplemented with 30 µg/ml tet, 100 µg/ml amp and 0.1 M 
glucose (TAG). The bacteria were grown at 37°C/ON. 
 
To determine the selection output, volumes of 10 µl infected culture were removed prior to 
centrifugation and transferred to a microtiter plate. Dilution series were prepared for each 
culture in 2x YT according to Table 2. 3µl of each dilution was spotted onto a BA85/20 
nitrocellulose membrane (Whatman) that was laid on top of LA-amp dishes. The dishes were 
incubated at 37°C/ON. The number of cfu/ml present in the original culture was calculated 
using the formula (cfu x dilution-1 x 1000)/3. 
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Table 2: Overview of dilutions made in titration of panning output 
Dilution Gradient 2 x YT Transfer 
A 10-1 90 µl 10 µl from culture 
B 10-2 90 µl 10 µl from A 
C 10-3 90 µl 10 µl from B 
D 10-4 90 µl 10 µl from C 
E 10-5 90 µl 10 µl from D 
F 10-6 90 µl 10 µl from E 
G 10-7 90 µl 10 µl from F 
 
 
The phagemid-containing bacteria were scraped from the large bio-assay dishes using 10 ml 
2xYT per dish and a glass spreader. Scraped bacteria were diluted to OD600nm 0.05 in 50 ml 
2xYT supplemented with TAG and incubated with shaking at 220rpm/37°C in INFORS HT 
(VWR) until OD600nm reached 0.1. Helper phage M13K07 or DeltaPhage was then added to 
the cultures at multiplicity of infection (MOI) 20. The cultures were further incubated at 
80rpm/37°C/30min and subsequently at 200rpm/37°C/30min. The bacteria cells were pelleted 
by centrifugation at 3220xg/15min/RT using Centrifuge 5810R (Eppendorf). The supernatants 
were discarded and the pellets were gently re-suspended in 50 ml 2xYT supplemented with 
100 µg/ml amp and 50 µg/ml kan. The cultures were incubated at 220rpm/30°C/6h, before 
virion-containing supernatants were harvested by centrifugation at 3220xg/4°C/30min and 
further sterile filtrated using 0.22 µm filters (Sarstedt, Nümbrecht, Germany). The 
supernatants were mixed with 1/5 volume of PEG/NaCl, and incubated in ice slurry at 
4°C/ON to precipitate the virions. The precipitated virions were concentrated and treated as in 
3.2.1. 
 
3.3.4 Calculation of phage enrichment 
 
Enrichment factor (EF) is defined as ratio from current selection round divided by the ratio 
from previous round. The ratio was obtained by dividing the phage output (cfuamp/ml) on the 
phage input (cfuamp/ml) in a selection round.  
 
The total EF was calculated by multiplying the EFs found for each selection round.  
Total enrichment factor: I x II x III, where I = round 2/round 1, II= round 3/round 2, 
III=round 4/round 3. 
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3.4 Analysis of phage libraries 
3.4.1 Analysis of library content by PCR 
 
The primers were ordered from Eurofins Genomics, Ebersberg. 
 
ColE1_fwd2:  5’-TGGATAACCGTATTACCGCCTTTG-3’ Tm 58.81°C 
scTCR380_Va_rv:  5’-GTGGCTTTCAGGAGGAGCTG-3’   Tm 59.11°C 
scFv_hVk_rv:  5´-GTGAGAGTGAATTCTGTCCCAGATC -3’  Tm 59.04°C 
 
Annealing temperatures were calculated using Oligonucleotide properties calculator and 
nearest neighbor (http://www.basic.northwestern.edu/biotools/oligocalc.html). Amplification 
was done with Phusion HotStart DNA polymerase (Thermo Scientific). PEG precipitated 
phage libraries were used as template and each library sample was tested with both primer 
pairs. The PCR reactions were set up according to Table 3. 
 
Table 3: PCR reaction setup 
Reagent  NC NC PC/NC Final Conc. 
Template 1μl 
Phage library 
 
 
1μl 
L1R1 
1 μl 
Control 
Plasmid 
Virions 
Or DNA 
dH2O 35.5 μl 35.5 μl 
 
36 μl 36.5 μl 35.5 μl 35.5 μl - 
dNTP 2 μl 2 μl 2 μl 2 μl 2 μl 2 μl 0.2mM 
ColE1_fwd2 0.5 μl 0.5 μl 0.5 μl  0.5 μl 0.5 μl 0.5μM 
scTCR_380_rv 0.5 μl  0.5 μl  0.5 μl  0.5μM 
scFv_hVk_rv  0.5 μl 0.5 μl   0.5 μl 0.5μM 
5x Phusion HF buffer 10 μl 10 μl 10 μl 10 μl 10 μl 10 μl 1x 
Phusion DNA Pol’ 0.5 μl 0.5 μl 0.5 μl 0.5 μl 0.5 μl 0.5 μl 0.02U/μl 
Total 50 μl 50 μl 50 μl 50 μl 50 μl 50 μl  
 
 
The PCR program used is given in Table 4 and was carried out using Doppio PCR cycler 
(VWR). To visualize the PCR products 1 µl of each reaction sample was prepared for gel	  
electrophoresis (described in detail in 3.5.2). 
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Table 4: PCR program used for amplification of phagemid or DNA plasmid 
Step Temperature Time 
Initial denaturation 98°C 3min 
Touchdown   
Denaturation 98°C 10sec 
Annealing Start: 72°C 30sec 
 End: 58°C  
 Steps: 7  
Extension 72°C 15sec 
Rep: 20   
Denaturation 98°C 10sec 
Annealing 58°C 30sec 
Extension 72°C 15sec 
Final extension 72°C 5min 
Hold at 4°C 24h 
 
 
3.4.2 Polyclonal ELISA 
 
MaxisorpTM microtiter plates (Corning Inc.) were coated with 1 µg/well NA (Thermo 
scientific) in 100 µl PBS pH 7.4 at 4°C/ON. The wells were blocked with 300 µl/well PBST 
containing 4% w/v nonfat dried milk powder (AppliChem) for 1 hour at RT. 125 ng 
biotinylated pMHC was added per well in 100 µl PBST (corresponding to 20 nM/well) and 
incubated for 1h/RT. 25 µl phage library sample diluted in 75 µl block solution was added to 
the appropriate wells and incubated for 1h/RT. Bound phage were detected with anti-M13-
HRP (1:5000) in 100 µl PBST for 1h/RT. Following incubation of each layer the wells were 
washed automatically 3x with 250µl PBST using a Skan washer (Molecular devices). The 
wells were developed by adding 100 µl TMB soluble substrate (Calbiochem, Darmstadt, 
Germany) to each well and the absorbance was measured at 620nm after 25 min using a 
sunrise ELISA reader device (TECAN). The reaction was stopped after 30 min. by adding 
100 µl 1M HCl to the wells and the absorbance was measured at 450nm. 
  
3.4.3 Single colony screening of selection output  
Single clone phagemid rescue 
 
Single colonies originating from selection output clones were randomly picked from LA-amp 
plates and grown overnight in 400 µl 2xYT-TAG in MegaBlock 96 well 2.2ml plates 
(Sarstedt, Nümbrecht, Germany) at 1100rpm/37°C in Titramax 1000 (Heidolph). The plates 
were sealed with AirPore tape sheet (Qiagen, Hilden, Germany). The cultures were re-
inoculated by transferring 10 µl to fresh deep well plates containing the same volume per well 
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of 2xYT-TAG and incubated for three hours at 1100rpm/37°C. The cultures were 
superinfected with 109 cfukan of DeltaPhage and incubated for 30 min with no agitation at 
37°C, followed by 30 min at 1100rpm/37°C. The cultures were pelleted by centrifugation at 
3220xg/15min/RT using Centrifuge 5810R (Eppendorf) and the supernatants were discarded. 
The pellets were gently resuspended in 400 µl pre-warmed 2xYT supplemented with 100 
µg/ml amp and 30 µg/ml kan, and the cultures were incubated with shaking at 
900rpm/30°C/ON, before cells were pelleted by centrifugation and the supernatant used in 
ELISA. 
 
Single clone ELISA  	  
MaxisorpTM microtiter plates (Corning Inc.) were coated with 1 µg/well NA (Thermo 
scientific) in 100 µl PBS pH 7.4 at 4°C/ON. The plates were incubated with 4% PBSTM for 
1h/RT to block the wells. 63 ng/well biotinylated DQ2.5-glia-α1a and DQ2.5-CLIP2 
(corresponding to 10 nM/well in a 100 µl volume) was added to separate plates and incubated 
for 1h/RT. Supernatants were transferred from the deep well plates to corresponding wells in 
two microtiter plates and thus incubated with both pMHC targets for 2h/RT. Following 
incubation of each layer the wells were washed automatically 3x with 250µl PBST using a 
Skan washer (Molecular devices). Phage detection and development was done as described in 
3.4.2, and absorbance was measured at 620nm after 25 min using a sunrise ELISA reader 
device (TECAN). The reaction was stopped after 30 min. by adding 100 µl 1M HCl to the 
wells and the absorbance was measured at 450nm. 
 
3.5 General methods 
3.5.1 Miniprep of single clones 
 
Single clones were inoculated from glycerol stock in 5 ml 2xYT-TAG and incubated with 
shaking at 220rpm/37°C/ON. 2 ml of the overnight cultures were centrifuged at 
3220xg/15min/RT using Centrifuge 5810R (Eppendorf). The plasmids were isolated from the 
bacteria using QIAprepTM Spin Miniprep Kit (Qiagen) and the DNA concentrations were 
measured using DS-11+ Spectrophotometer (DeNovix, Wilmington, Delaware). The clones 
were sequenced by the ABI lab core facility (Dept. of Biosciences, University of Oslo, 
Norway). To visualize the isolated plasmids 1 µl of each sample was prepared for gel 
electrophoresis. 
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3.5.2 Gel electrophoresis 
 
A 1% gel was prepared using 0.5 g agarose (Sigma-Aldrich), which was dissolved in 50 ml 
1xTAE buffer (40 nM Tris-acetate, 1 mM ethylenediaminetraacetic acid (EDTA)) by heating 
the solution to boiling point. 5 µl SYBR safe DNA gel stain (Life technologies) was added to 
the agarose solution before casting. DNA samples were mixed with 2 µl of 6x sample buffer 
and dH2O to a total volume of 12 µl and added to the wells in the gel. A DNA ladder was 
added in parallel (New England Biolabs, MA, USA). The gel electrophoresis was carried out 
in 1xTAE buffer at 90V for 45 minutes using Power pac 300 (Biorad) and the DNA was 
visualized using Gel DocTM EZ Imager (Biorad). 	  
3.5.3 Sequencing analysis  
 
DNA sequencing of the POI-encoding cassette was done using the two forward primers  
pQE-FP (5’-CGGATAACAATTTCACACAG-3’) and  
Yol_frwd (5’-GTGAATTTTCAGAAGCACGC-3’). Samples were prepared for sequencing 
by mixing app. 20 ng/µl miniprep with milli-q H2O in a total volume of 9 µl and then adding 
1 µl of a 10 µM primer solution. The ABI-lab core facility at Dept. of Biosciences, University 
of Oslo, Norway was used and the data obtained was analyzed using the tools listed in Table 
5. 
 
Table 5: Tools used for sequence analysis 
Analysis Program Company/Software/ 
Developer 
Link 
Raw data analysis Sequence scanner Applied Biosystems http://www3.appliedbiosyst
ems.com 
Multiple sequence alignment Clustal Omega The European 
Bioinformatics Institute 
https://www.ebi.ac.uk/Tools
/msa/clustalo/ 
Multiple sequence alignment 
editor 
BioEdit  
V 7.1.3 
Tom Hall http://www.mbio.ncsu.edu/
BioEdit/bioedit.html 
TCR/IG V gene analysis  IMGT/V-QUEST IMGT http://www.imgt.org/IMGT
_vquest/share/textes/ 
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4. Results   
4.1 Phage selection on DQ2.5-glia-α1a 
4.1.1 Background  
 
In order to employ TCRs as trackers of antigen presentation the affinity has to be improved. 
This may be achieved by making phage libraries of TCRs with randomized amino acids in 
CDR loops, and by performing selections on specific target. For the development of such a 
reagent, scTCR s380 reactive to the immunodominat DQ2.5-glia-α1a epitope, a naturally 
occurring TCR derived from a CD lesion, was chosen to be the starting point for phage library 
construction. 
 
The library construction is described in supplementary 1. Briefly, the CDR3α and CDR3β 
amino acid loops of scTCR s380 were separately randomized. Different parts of the loops 
were targeted for mutagenesis to generate several sub-libraries, which were packaged into 
virion particles by rescued with M13K07 and DeltaPhage giving mono- and multivalent 
display, respectively. The scTCR s380 variants were expressed as fusion proteins to the pIX 
capsid. 
 
The first attempt to affinity mature scTCR s380 is described in supplementary 2. At that time, 
a naïve scFv phage library had recently been panned against the same target, DQ2.5-glia-α1a, 
using the very same laboratory environment (Høydahl et al., unpublished). Notably, this 
particular scFv library had been pre-enriched for scFvs, that performed particularly well in 
E.coli, by functional pL purification [97]. Thus, these intersecting panning campaigns led to 
contamination of the scTCR s380 phage libraries with various DQ2.5-glia-α1a specific scFv 
clones, as revealed in the target screening following panning of the scTCR libraries. 
Backtracking of the contamination using PCR revealed that the original scTCR s380 phage 
library stocks were clean, and thus could be used in a second attempt to affinity mature 
scTCR s380 (supplementary 3). 
 
Phages from sub-libraries that were randomized in the same CDR3 loop were pooled before 
selection, resulting in the libraries listed in Table 6. 
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Table 6: Libraries used for panning 
Library no Library namea 
L1 scTCR s380 CDR3α – M13K07 
L2 scTCR s380 CDR3β – M13K07 
L3 scTCR s380 CDR3α – DeltaPhage 
L4 scTCR s380 CDR3β – DeltaPhage 
a Libraries were prepared by Høydahl (unpublished). 
 
Initial experiments were performed to prepare an optimized selection protocol (supplementary 
4-6).  
 
4.1.2 Selection round one and two 
 
To limit the number of phage with unspecific binding properties, the libraries were first 
negatively selected on biotinylated HLA-DQ2.5 harboring the irrelevant peptide CLIP2. 
Phages that remained unbound were subsequently subjected to positive selection on the 
relevant peptide antigen glia-α1a bound in the context of biotinylated HLA-DQ2.5.  
 
In order to capture the majority of phages displaying scTCR variants with the relevant 
specificity, HLA-DQ2.5-glia-α1a was given in great excess compared to the number of 
phages in the first round. However, to increase the chance of isolating high affinity scTCRs, 
the concentration of antigen in the positive selection was reduced by a tenfold for each round 
of selection. 
 
To select for increased off-rate, free soluble DQ2.5-glia-α1a (referred to as competitor) was 
added in excess in two rounds to the bead-captured phage-antigen complexes to capture the 
dissociating scTCR phage, and thus preventing them from re-binding to the antigen on the 
bead. This was done starting from the second round of selection. 
 
Phages that were eluted in the second addition of competitor (E2) and phages that were eluted 
from the beads by TEA (E3) were used to infect E.coli. To limit growth bias caused by clonal 
differences, the infected bacterial cells were further grown on large LB-TAG Bio-assay 
dishes. Thus, starting from the second round of selection, every library that was subjected to 
selection, became two sub-libraries. Both were subsequently channeled into the following 
selection round (Figure 7 A). An overview of the selection strategy is shown in Figure 7 B. 
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Figure 7: (A) Diagram showing how one library evolves through each round of selection to give 
several sub-libraries. (B) Overview of the selection strategy. 
 
4.1.3 Detection of scTCR- and scFv-encoding phagemid by PCR 
 
Due to the scFv phage library contamination (supplementary 2), the scTCR phage libraries 
were monitored throughout the new selection. The phage libraries resulting from each round 
of selection were screened for presence of phagemid harboring scTCR s380 and phagemid 
harboring human scFv with kappa light chain. This was conducted by PCR (described in 
3.4.1). A common forward primer that anneal to the same vector element in both phagemids 
was also used. Furthermore, in order to discriminate between the two phagemids, the reverse 
primers were design to anneal to different regions in the scTCR and scFv cassettes to yield 
products of different sizes. The reaction samples were analyzed by gel electrophoresis 
(described in 3.5.2).  
 
A 
LX#
R2E3/
R3E3/
R4E3#
LX/R1#
LX/R2E3#
LX/R2E2/R3E2#
LX/R2E2#
LX#
R2E2/#
R3E2/#
R4E2#
LX#
R2E2/
R3E2/
R4E3#
LX#
R2E2/
R3E3/
R4E2#
LX#
R2E2/
R3E3/
R4E3#
LX#
R2E3/
R3E2/
R4E2#
LX#
R2E3/
R3E2/
R4E3#
LX#
R2E3/
R3E3/
R4E2#
Library#X#
Round 1 
Round 2 
Round 3 
Round 4 
LX/R2E2/R3E3# LX/R2E3/R3E2# LX/R2E3/R3E3#
R1 
Neg. selection on DQ2.5-CLIP2 
Positive selection on DQ2.5-glia-αIa  
R2 
Neg. selection on DQ2.5-CLIP2 
Positive selection on DQ2.5-glia-αIa  
10x less Ag 
Excess competitor 
R3 
Neg. selection on pL 
Neg. selection on DQ2.5-CLIP2 
Positive selection on DQ2.5-glia-αIa  
100x less Ag 
Excess competitor 
R4 
Neg. selection on pL 
Neg. selection on DQ2.5-CLIP2 
Positive selection on DQ2.5-glia-αIa  
100x less Ag 
Excess competitor 
B 
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Figure 8: Gel	  electrophoresis	  showing	  the	  result	  of	  PCR	  analysis	  of	  the phage libraries resulting from 
selection R1 (A) and selection R2 (B). Two and two wells are marked according to the library 
template that was used. The first and the second well corresponds to the PCRs performed with primer 
set specific for scTCR s380- and scFv-encoding phagemid, respectively. Six controls were included in 
the PCRs and are shown. 100 bp DNA ladder was included in all gels and the relevant fragments are 
marked. 	  
As seen, PCR products were not generated in absence of template or primers (Figure 8 A-B). 
When purified plasmids encoding scTCR s380 and human scFv also were used as template, 
both primer sets resulted in amplification of fragments of expected size (Figure 8 A-B). An 
additional band corresponding to a fragment of app. 700 bp was obtained with the scFv 
primer set when pGALD9ΔL scTCR s380 was used as template. No band was observed when 
the scTCR primer set was used with the scFv-encoding plasmid.  
 
For the library samples resulting from selection R1, bands of expected size of about 500bp 
were obtained using the scTCR primer set (Figure 8 A), indicating presence of scTCR s380 
phagemid throughout. With the scFv primer-set no bands of expected size were obtained for 
any of the library samples, indicating that scFv phagemid was not present. However, again, 
the weak band at about 700 bp was observed for one of the library samples. 
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PCR analysis of the phage libraries from selection R2 revealed that three of eight libraries 
contained scFv-encoding phagemid, as bands corresponding to fragments of 1000bp were 
obtained using the scFv primer set (Figure 8 B). All eight libraries were also positive for 
scTCR-encoding phagemid, with clear bands of expected sizes obtained with the scTCR 
primer set. The eight libraries originated from the original four libraries. The contamination 
was found in two sister libraries, L1E2 and L1E3, and in L4E2. In L4E3, the sister library of 
L4E2, no contamination was found however.  
 
4.1.4 Negative selection of scFv-displaying phages 
 
In order to prevent or limit the propagation of scFv phagemids within and between the scTCR 
s380 CDR3α	  and	  CDR3β	  libraries, an additional step was included in the selection protocol as 
of round three. Prior to negative selection on DQ2.5-CLIP2, the libraries were negatively 
selected on pL (described in 3.3.1). pL interacts with high affinity with variables domains of 
the kappa light chain family (except V domains of the VκII family) [98, 99] and have 
previously been used for functional purification of phage libraries, including the scFv library 
in question here [97]. Only phages that were not bound to pL were channeled into R3 and R4 
selections as before.  
 
To find out whether or not pre-selection on pL had been successful in preventing scFv 
propagation, the libraries resulting from the third and fourth round of selection was analyzed 
by PCR as in 4.1.3 and as described in methods (3.4.1). The reaction samples were visualized 
by gel electrophoresis (described in 3.5.2).	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Figure 9: Gel electrophoresis showing the result of PCR analysis of the phage libraries resulting from 
selection R3 (A) and from selection R4 (B). Two and two wells are marked according to the library 
template that was used. The first and the second well correspond to the PCRs performed with primer 
set specific for scTCR s380- and scFv-encoding phagemid, respectively. Six controls were included in 
the PCRs and are shown. 100 bp DNA ladder was included in all gels and the relevant fragments are 
marked. 	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Seven of the twelve libraries were positive for scFv-encoding phagemid, as the PCR resulted 
in amplification of a 1000 bp fragment with the scFv primer set. Furthermore, nine of the 
twelve libraries derived from selection R3 were positive for scTCR-encoding phagemid, as 
the PCR resulted in amplification of a 500 bp fragment with the scTCR primer set. For two of 
the libraries no bands were obtained with either of the primer sets. Thus, the contamination 
was indeed present after negative selection on pL, but as the scTCRs were also present, the 
scFv displaying phages had not overgrown the culture. 
 
Of the 22 libraries derived from selection R4, one L1 sub-library was positive for scTCR-
encoding phagemid only. 18 libraries were positive for both scTCR-encoding and the scFv-
encoding phagemids. Bands of expected size and of varying strengths were obtained with 
both primer-sets. For two L3 sub-libraries no bands were obtained with either of the primer 
sets.  
 
Analysis after selection R3 and R4 revealed that scTCR is present, even if the occurrence of 
scFv-encoding phagemid increased with every round.  	  
4.1.5 Phage enrichment 
 
The selection process is designed to enrich for target specific clones, and whether selection 
has lead to enrichment, can be predicted by calculating the EF. In order to calculate the EF, 
the number of phages that are added to each selection round (input) and the number of phages 
that are recovered in each round (output) has to be determined.  
 
The initial phage library titers (R0) were determined prior to selection in order to perform 
selection round one with a complexity of 1000 based on library diversity. The calculated 
inputs corresponding to this complexity were based on titers obtained by spot titration 
(described in 3.2.2) of the generated libraries. Starting from round two, 100 μl amplified and 
precipitated phage output from the previous round was used as input in the following round. 
The concentration in this input volume was determined by spot titration after all four selection 
rounds were completed. The phage output was determined directly after each selection round, 
as described in 3.3.3. The enrichment factors were calculated for the various libraries between 
the selection rounds and are shown in Table 7. 
  
  
 41 
Table 7: Phage enrichment 
 
 
 
 
 
 
 
 
 
L1/R2E3/
R3E3/R4E3)
!
Input:!1.1x1011!
Output:!1.6x106!
Ra0o:!1.5x1035!
E.F.:!469!(II)!
Input:!5x1012!
Output:!2x105!
Ra0o:!4x1038!
L1/R2E2/
R3E2/R4E2)
!
Input:!1.7x1011!
Output:!1.46x106!
Ra0o:!8.6x1036!
E.F.:!938!(III)!
L1/R2E2/
R3E2/R4E3)
!
Input:!1.7x1011!
Output:!64!
Ra0o:!3.8x10310!
E.F.:!0.041!(II)!!
L1/R2E2/
R3E3/R4E2)
)
Input:!1.6x1011!
Output:!1.3x104!
Ra0o:!8.13x1038!
E.F.:!0.27!(II)!
L1/R2E2/
R3E3/R4E3)
!
Input:!1.6x1011!
Output:!6.67x105!
Ra0o:!4.2x1036!
E.F.:!!13.9!(II)!
L1/R2E3/
R3E2/R4E2)
!
Input:!8.0x1011!
Output:!1.3x103!
Ra0o:!1.7x1039!
E.F.:!0.038!!(II)!
L1/R2E3/
R3E2/R4E3)
!
Input:!8.0x1011!
Output:!804!
Ra0o:!1x1039!
E.F.:!0.024!(II)!
L1/R2E3/
R3E3/R4E2)
!
Input:!1.1x1011!
Output:!3.1x106!
Ra0o:!2.8x1035!
E.F.:!909!(II)!
Library)1)(L1):))
scTCR)s380)CDR3α/M13K07)
Round 1 
Round 2 
Round 3 
Round 4 
L1 
Input:!1.2x1012 !!
Output:!3.0x104!
Ra0o:!2.5x1038!
E.F.:!0.63!(I)!!
L1/R2E2 
Input:!8.3x1011 !!
Output:!7.6x103!
Ra0o:!9.16x1039!
E.F.:!0.36!(II)!!
L1/R2E2/R3E2 
Input:!8.3x1011 !!
Output:!2.5x105!
Ra0o:!3.0x1037!
E.F.:!12!!(II)!!
Input:!8x1012 !!
Output:!3.4x105!
Ra0o:!4.25x1038!
E.F.:!3.4!(II)!!
Input:!8x1012! !!
Output:!2.5x105!
Ra0o:!3.1x1038!
E.F.:!2.5!(II)!!
Input:!1.2x1012 !!
Output:!1.5x104!!
Ra0o:!1.25x1038!
E.F.:!0.31!(I)!!
Total enrichment 
factor: 212.7 
L1/R2E2/R3E3 
L1/R2E3 
L1/R2E3/R3E2 L1/R2E3/R3E3 
Total enrichment 
factor: 0.009 
Total enrichment 
factor: 2 
Total enrichment 
factor: 105 
Total enrichment 
factor: 0.04 
Total enrichment 
factor: 0.025 
Total enrichment 
factor: 704.5 
Total enrichment 
factor: 363.5 
a 
Input:'1.5x1012 ''
Output:'4.5x105'
Ra2o:'3.0x1057'
E.F.:'6'(II)''
Input:'2x1012'
Output:'1x105'
Ra2o:'5x1058'
L2/R2E2/
R3E2/R4E2(
'
Input:'7.3x1011'
Output:'2.67x104'
Ra2o:'3.7x1058'
E.F.:'0.02'(III)'
L2/R2E2/
R3E2/R4E3(
'
Input:'7.3x1011'
Output:'1.6x106'
Ra2o:'2.2x1056'
E.F.:'1.3'(II)''
L2/R2E2/
R3E3/R4E2(
(
Input:'1.6x1011'
Output:'3.46x106'
Ra2o:'2.16x1055'
E.F.:'72'(II)'
L2/R2E2/
R3E3/R4E3(
'
Input:'1.6x1011'
Output:'2.26x107'
Ra2o:'1.4x1054'
E.F.:''466.7'(II)'
Round 2 
Round 3 
Round 4 
L2 
Input:'2.0x1011 ''
Output:'5.2x103'
Ra2o:'2.6x1058'
E.F.:'0.52'(I)''
L2/R2E2 
Input:'8.9x1011 ''
Output:'1.5x106'
Ra2o:'1.7x1056'
E.F.:'65.3'(II)''
L2/R2E2/R3E2 
Input:'8.9x1011 ''
Output:'96'
Ra2o:'1.1x10510'
E.F.:'0.004'(II)''
Input:'1.5x1012' ''
Output:'80'
Ra2o:'5.3x10511'
E.F.:'0.001'(II)''
Input:'2.0x1011 ''
Output:'1.0x104''
Ra2o:'5.0x1058'
E.F.:'1'(I)''
Total enrichment 
factor: 0.7 
L2/R2E2/R3E3 
L2/R2E3 
L2/R2E3/R3E2 L2/R2E3/R3E3 
Total enrichment 
factor: 44.1 
Total enrichment 
factor: 432 
Total enrichment 
factor: 2800.2 
Library(2((L2):((
scTCR(s380(CDR3β/M13K07(
Round 1 
a a 
A 
B 
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a The libraries in the white boxes were not rescued due to low phage numbers and were therefore not propagated into the next round of 
selection 
b The enrichment factor for one of the L3 sub-libraries could not be calculated because the output from R4 was not available 
 
 
Enrichment was found in four of eight L1 and in three of four L2 subgroups. The same was 
found in one of five L3 sub-groups and in four of six L4 sub-groups. Thus, the results do 
indeed indicate enrichment of target specific clones.  
 
 
L3/R2E3/
R3E3/R4E3(
!
Input:!1.6x1011!
Output:!1888!
Ra1o:!1.2x1048!
E.F.:!52.2!(II)!
Input:!5x1012!
Output:!1.67x105!
Ra1o:!3.4x1048!
L3/R2E2/
R3E2/R4E2(
!
Input:!4.7x1011!
Output:!6976!
Ra1o:!1.5x1048!
E.F.:!1!(III)!
L3/R2E2/
R3E2/R4E3(
!
Input:!4.7x1011!
Output:!1.3x104!
Ra1o:!2.8x10.8!
E.F.:!1.9!(II)!!
L3/R2E3/
R3E2/R4E2(
!
Input:!3.4x1012!
Output:!4992!
Ra1o:!1.5x1049!
E.F.:!2.9!!(II)!
L3/R2E3/
R3E2/R4E3(
!
Input:!3.4x1012!
Output:!N/A!
Ra1o:!N/A!
E.F.:!N/A!(II)!
L3/R2E3/
R3E3/R4E2(
!
Input:!1.6x1011!
Output:!1.0x106!
Ra1o:!6.3x1046!
E.F.:!2.7x104!(II)!
Round 1 
Round 2 
Round 3 
Round 4 
L3 
Input:!5.1x1011 !!
Output:!1200!
Ra1o:!2.4x1049!
E.F.:!0.07!(I)!!
L3/R2E2 
Input:!8.9x1011 !!
Output:!1.3x104!
Ra1o:!1.5x1048!
E.F.:!6.3!(II)!!
L3/R2E2/R3E2 
Input:!8.9x1011 !!
Output:!200!
Ra1o:!2.2x10410!
E.F.:!0.09!(II)!!
Input:!2.3x1012 !!
Output:!1184!
Ra1o:!5.1x10410!
E.F.:!0.076!(II)!!
Input:!2.3x1012! !!
Output:!540!
Ra1o:!2.3x10410!
E.F.:!0.034!(II)!!
Input:!5.1x1011 !!
Output:!3400!!
Ra1o:!6.7x1049!
E.F.:!0.19!(I)!!
Total enrichment 
factor: 0.441 
L3/R2E2/R3E3 
L3/R2E3 
L3/R2E3/R3E2 L3/R2E3/R3E3 
Total enrichment 
factor: 0.838 
Total enrichment 
factor: 0.042 
Total enrichment 
factor: N/A 
Total enrichment 
factor: 174.4 
Total enrichment 
factor: 0.337 
Library(3((L3):((
scTCR(s380(CDR3α/DeltaPhage(
a 
b 
Input:'2x1012'
Output:'2.7x105'
Ra2o:'1.4x1057'
L4/R2E2/
R3E2/R4E2(
'
Input:'3.3x1011'
Output:'2.0x106'
Ra2o:'6.1x1056'
E.F.:'14'(III)'
L4/R2E2/
R3E2/R4E3(
'
Input:'3.3x1011'
Output:'8.0x106'
Ra2o:'2.4x1055'
E.F.:'56'(II)''
L4/R2E2/
R3E3/R4E2(
(
Input:'3.0x1011'
Output:'4.0x105'
Ra2o:'1.3x1056'
E.F.:'29'(II)'
L4/R2E2/
R3E3/R4E3(
'
Input:'3.0x1011'
Output:'5.3x106'
Ra2o:'1.8x1055'
E.F.:''400'(II)'
L4/R2E3/
R3E2/R4E2(
'
Input:'2.6x1011'
Output:'6.0x103'
Ra2o:'2.3x1058'
E.F.:'18'(II)'
L4/R2E3/
R3E2/R4E3(
'
Input:'2.6x1011'
Output:'268'
Ra2o:'1x1059'
E.F.:'0.7'(II)'
Round 2 
Round 3 
Round 4 
L4 
Input:'6.0x1011 ''
Output:'9.0x103'
Ra2o:'1.5x1058'
E.F.:'0.11'(I)''
L4/R2E2 
Input:'4.4x1012 ''
Output:'1.9x106'
Ra2o:'4.3x1057'
E.F.:'29'(II)''
L4/R2E2/R3E2 
Input:'4.4x1012 ''
Output:'2.0x105'
Ra2o:'4.5x1058'
E.F.:'3'(II)''
Input:'6.6x1011 ''
Output:'888'
Ra2o:'1.3x1059'
E.F.:'0.087'(II)''
Input:'6.6x1011' ''
Output:'52'
Ra2o:'7.9x10511'
E.F.:'0.00005'(II)''
Input:'6.0x1011 ''
Output:'9.2x103''
Ra2o:'1.5x1058'
E.F.:'0.11'(I)''
Total enrichment 
factor: 45 
L4/R2E2/R3E3 
L4/R2E3 
L4/R2E3/R3E2 L4/R2E3/R3E3 
Total enrichment 
factor: 179 
Total enrichment 
factor: 10 
Total enrichment 
factor: 132 
Total enrichment 
factor: 0.17 
Total enrichment 
factor: 0.007 
Library(4((L4):((
scTCR(s380(CDR3β/DeltaPhage(
Round 1 
a 
a 
D 
C 
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4.2 Screening of scTCR phage libraries 
4.2.1 Polyclonal ELISA of M13K07-rescued R4 phage output 
 
To investigate whether or not any of the phage libraries contained binders to DQ2.5-glia-α1a, 
a polyclonal ELISA (described in 3.4.2) was performed as shown in Figure 10 A. In short, the 
output from round four was rescued with M13K07 and precipitated phages were tested for 
binding to DQ2.5-glia-α1a and DQ2.5-CLIP2. Binding of scTCR s380 wt displayed on phage 
to DQ2.5-glia-α1a is not detected in ELISA, and is probably due to the low affinity. The same 
ELISA can therefore be used to check for specific binders with improved affinity. 	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Figure 10: Polyclonal ELISA of phage libraries from selection R4. (A) Schematic setup of ELISA used 
for testing of phage library binding to DQ2.5 -glia-α1a and DQ2.5-CLIP2. (B) ELISA binding of the 
various sub-libraries. The library name was shortened by removal of RX. (B) ELISA binding of control 
samples. The experiment was performed in duplicate and the mean ±sd is shown. The phage libraries 
were also added to empty wells to monitor binding to the blocking agent (data not shown).  
 
Many of the M13K07-rescued phage libraries showed preferential binding to DQ2.5-glia-α1a 
(Figure 10 B). Three of seven L1 subgroups and three of six L3 subgroups were positive for 
binding, and so were all four L2 subgroups and four of five L4 subgroups. Two of the reactive 
L3 libraries had particularly low background binding to DQ2.5-CLIP2. 
 
Both DQ2.5-glia-α1a and DQ2.5-CLIP2 complexes were detected with anti-DQ2 2.12.E11 
antibody (Figure 10 C) at high and similar signal intensity, indicating that equal and sufficient 
amounts of target molecules were available in the wells for phage library binding. Phages 
displaying the I-Ed restricted scTCR 4B2A1 at low valence were negative for binding to 
DQ2.5-glia-α1a [100]. Phages displaying scFv anti-NIP at high valence showed strong 
antigen-specific binding to BSA-NIP. 
 
Phages displaying wt scTCR s380 on pIX at low valence showed no reactivity in line with 
unpublished results from the research group. Thus, the positive binding signals obtained for 
several of the phage libraries might be caused by the presence of specific clones with higher 
affinity than the wt clone.  
 
4.2.2 Phage packaging of single clones and ELISA 
 
Since L2/E3/E2/E2 showed preferential binding to HLA-DQ2.5 glia-­‐α1a	   in	   the	  polyclonal	  ELISA,	   this output was selected for further investigation at single clone level. To screen for 
high affinity binders, a	   total	   of	  186 single clones were separately grown and rescued with 
C 
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DeltaPhage to achieve multivalent display of the fusion protein, and the packaged virions 
were subsequently tested in ELISA for binding to HLA-DQ2.5 glia-­‐α1a	  and	  -DQ2.5 CLIP2	  
(described in 3.4.3).	   The clones were grown in a total of two deep well plates and the 
following three controls were included in separate wells in each plate; pGALD9ΔL-scFv anti-
NIP, wt pGALD9ΔLFN- scTCR s380 and E. coli SS320 cells without phagemid.  
 
 
	  
	  
 
 
A 
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Figure 11: Single colony screening of L2/E3/E2/E2 from selection R4. The same ELISA setup as 
depicted in Figure 10 A was used. (A) ELISA measurements of single clones that were grown in deep 
well plates and named	  according	  to	  plate	  number	  and	  position	  in	  the	  plate,	  e.g.	  1-­‐A1;	  plate	  number	  
1,	  well	  A1.	  The controls are shown as the three last bars in the second and fourth graph. (B) ELISA	  
measurements	  for	  control	  samples	  that	  were	  included	  for	  the	  ELISA	  setup.	  
 
Background binding of the negative controls to HLA-DQ2.5 glia-α1a was measured up to	  
A620nm 0.06.	  The single clones that were screened were all negative for binding to HLA-
DQ2.5 glia-α1a, showing A620nm values below the background signal. The pGALD9ΔL-
scFv anti-NIP controls that were included in the phage packaging showed strong antigen-
specific binding (Figure 11 A), indicating that the conditions were satisfactory for phage 
production. 
 
Both DQ2.5-glia-α1a and DQ2.5-CLIP2 complexes were detected with anti-DQ2 2.12.E11 
antibody (Figure 11 B), with signal intensities in the same range indicating that the target 
molecules were present in roughly equal amounts per well. As seen before (4.2.1), 
preferential binding to DQ2.5-glia-α1a was observed for the phage library, that the single 
clones were derived from, L2/E3/E2/E2, which also confirms that sufficient quantities of 
pMHC were available for phage binding. In line with unpublished data from the research 
group, phages displaying wt scTCR s380 on pIX at high valence were negative for binding to 
B 
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DQ2.5-glia-α1a. Again, phages displaying scFv anti-NIP at high valence showed strong 
antigen-specific binding towards BSA-NIP. 
 
Even though this method is known to give false negatives and positives (Løset G.Å., personal 
communication), it was surprising that there were no positive hits among the 186 clones that 
were tested, especially because the phage library that the clones came from showed strong 
preferential binding for the second time. Further investigation was needed. 	  
4.2.3 Sequencing of single clones 	  
To determine the identity of a portion of the screened clones, 22 single phagemids were 
isolated from ON cultures (described in 3.5.1), and the POI-encoding cassette was sequenced 
(descried in 3.5.3). 
 
The POI-encoding cassettes of all 22 phagemids were identical in sequence. This sequence 
could not be aligned with the scTCR s380 wt sequence, but alignment with three relevant 
scFv anti DQ2.5-glia-α1a clones gave a match, namely, a scFv anti DQ2.5-glia-α1a clone that 
was dominating the R3 output of the recent scFv phage library selection. Specific binding of 
the scFv anti DQ2.5-glia-α1a in soluble form has been detected in ELISA repeatedly. This 
was not observed in the library screening (4.2.2) however. 	  	  
4.3 Trouble shooting 
4.3.1 Spot titration of scFv phage cultures 
 
To investigate how efficiently the scFv anti DQ2.5-glia-α1a	   clone was produced upon 
DeltaPhage rescue in the screening, spot titration (described in 3.2.2) was performed on the 
supernatants of the same 22 samples that were sequenced (4.2.3). The two pGALD9ΔL-scFv 
anti-NIP controls were included in the titration. The results are illustrated in Figure 12 and 
revealed that the end titers obtained for the clone were low compared to the two controls. 
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Figure 12: End titers of the scFv anti DQ2.5-glia-α1a	  clone	  after DeltaPhage-rescue in screening. 
The results are given as amp resistant colony forming units (cfuamp) per ml. 
 
Even though a source for pIX capsid was missing when the scFv clone, encoded in pSEX for 
display on pIII, was rescued with DeltaPhage in the amber non-supressor host E. coli SS320, 
infectious phage particles were produced. However, the appearance and structure of these 
particles is unknown. The lack of signal in the single clone ELISA (4.2.2) could thus most 
likely be explained by the low titers, if the rescued phages display the fusion protein at all. 
 
4.3.2 Phagemid rescue of pSEX scFv anti-DQ2.5-glia-α1a	  and	  ELISA 
 
To study the specific binding properties of scFv anti-DQ2.5-glia-α1a, an ELISA was 
performed. In short, the phagemid was rescued with either M13K07 or DeltaPhage in multiple 
parallels using the same conditions as for library rescue, and PEG precipitated phages were 
tested using the same setup and phage input as in the polyclonal ELISA (4.2.1). 	  
 
 
 
 
A B 
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Figure 13: Phage ELISA on scFv anti-DQ2.5-glia-α1a. (A) ELISA binding of scFv anti-DQ2.5-glia-
α1a phages to DQ2.5-glia-α1a, DQ2.5-CLIP2 and to the blocked coat (termed background), including 
three M13K07-rescued and three DeltaPhage-rescued samples of the clone. (B) ELISA binding of 
control samples. The ELISA experiment was performed in duplicate and the mean ±sd is shown.  
 
The results confirmed that when the scFv-encoding pSEX phagemid is rescued with M13K07, 
strong preferential binding to HLA-DQ2.5-glia-α1a is detected (Figure 13 A). However, 
antigen binding was not detected when rescue was performed with DeltaPhage. This could 
possibly be exploited to limit the rescue of scFv phagemids present in the scTCR phage 
libraries, and to knock down the signals caused by scFv clones in the polyclonal ELISA. 
 
4.4 Screening of scTCR phage libraries with new discovery 
4.4.1 Polyclonal ELISA of DeltaPhage-rescued R4 phage output  
 
To further investigate if any of the phage libraries contained antigen specific scTCR s380 
clones, the output from selection round four was rescued with DeltaPhage and precipitated 
phages were tested in ELISA for binding to DQ2.5-glia-α1a and DQ2.5-CLIP2.  
 
A 
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Figure 14: Polyclonal ELISA of R4 phage libraries rescue by DeltaPhage. The same ELISA setup as 
depicted in Figure 10 was used. (A) ELISA binding of the various sub-libraries to DQ2.5-­‐glia-­‐α1a	  and	  
DQ2.5-­‐CLIP2.	  (B)	  ELISA	  binding	  of	  control	  samples.	  The	  experiment	  was	  performed	  in	  duplicate	  
and	  the	  mean	  ±sd	  is	  shown.	  The	  phage	  libraries	  were	  also	  added	  to	  empty	  wells	  to	  monitor	  binding	  
to	  the	  blocking	  agent	  (data	  not	  shown). 
 
Compared to ELISA results obtained with M13K07-rescued R4 phage output, most of 
equivalent DeltaPhage-rescued libraries showed reduced or no reactivity towards  
DQ2.5-glia-α1a. However, three subgroups of L3 were positive and one of them even showed 
increased binding to DQ2.5-glia-α1a. Interestingly, L3 is a CDR3α library that was rescued 
with DeltaPhage initially, and has been through two rounds of selection with high valence 
display.  	  
4.4.2 Phage packaging of single clones and ELISA 
 
The two libraries with strongest signal in the polyclonal ELISA (4.4.1), L3/E3/E2/E2 and 
L3/E3/E3/E3, were selected for further investigation at single clone level. The screening for 
high affinity binders was conducted in the same manner as in 4.2.2. Thus, 186 clones were 
analyzed from each of the two libraries and grown in a total of four deep well plates. The 
following three controls were scattered to different wells in each deep well plate; 
pGALD9ΔL-scFv anti-NIP, wt pGALD9ΔLFN- scTCR s380 and E. coli SS320 cells without 
phagemid.  
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Figure 15: Single colony screening of L3/E3/E2/E2 (A-B) and L3/E3/E3/E3 (B-C) from selection R4. 
ELISA measurements for the individual clones are shown. The clones are named	  according	  to	  plate	  
number	  and	  position	  in	  the	  plate,	  e.g.	  1-­‐A1;	  plate	  number	  1,	  well	  A1.	  The three controls are indicated 
by name. (E) ELISA	  measurements	  for	  control	  samples	  that	  were	  included	  for	  the	  ELISA	  setup. The 
same ELISA setup as depicted in Figure 10 A was used.	  	  
Two distinct clones, namely 1-A12 and 4-E4, showed A620nm values above the highest 
background signal, making them interesting candidates. To determine their identity, their 
phagemids were isolated from ON cultures and the POI-encoding cassette was sequenced. To 
get an overview of the clone population, an additional 22 clones were sequenced. The quality 
of the obtained sequences was low. However, the identity of the two candidate clones were 
revealed and proved to be clones of scFv origin.  
  
E 
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5. Discussion 
 
The low affinity of native TCRs for pMHC prevents the direct use of a soluble TCR as a 
detection reagent [41]. The DQ2.5-glia-α1a restricted TCR 380, which has all the 
characteristics of a disease driven T cell response, was chosen for affinity maturation. As the 
glia-α1a T cell epitope is one of two immunodominant gluten peptides [78], a specific DQ2.5-
glia-α1a tracker should be highly useful in the characterization of antigen presentation in CD. 
In addition to the intrinsically low affinity of the TCR for pMHC, the lack of reliable 
expression systems for soluble TCRs have slowed down their development as recombinant 
tools. 
 
We have previously shown that FkpA overexpression has a major effect on soluble 
periplasmic expression of scTCRs as well as on the display levels on the surface of phage [45, 
46]. FkpA encoding phagemids were therefore used, enabling chaperone co-expression during 
selection. Several reports have been published, highlighting the effect of introducing 
stabilizing mutations in the scTCR format affecting both yield and protein stability. In line 
with this, the wt TCR 380 was stabilized by introduction of three point mutations [42, 49], 
which resulted in increased display levels on pIX capsid and increased yield of soluble scTCR 
(Neuman, Høydahl et al, unpublished). 
 
The scTCR s380 was cloned into the phagemid vector for pIX display. We have previously 
reported a side-by-side comparison of display on pIII with display on pVII and pIX, and 
shown that affinity selections of folded domains are particularly efficient when displayed on 
pVII or pIX [6].  
 
The CDR3α and CDR3β loops of s380 were selected for initial randomization to generate 
phage libraries based on the assumption that standard diagonal docking mode applied. Crystal 
structures of numerous of TCR-pMHC complexes have shown that most peptide contacts are 
made by the CDR3 loops of the TCR and thus are likely to be the key determinants of TCR 
specificity. Targeting of the CDR1 and CDR2 loops, which contacts the MHC molecule 
primarily, could lead to loss of MHC restriction and thus specificity [2]. Furthermore, recently 
reported crystal structures of TRAV7-2+ TCRs in complex with DQ2.5-glia-α1a and DQ2.5-
glia-α2 were indeed shown to use standard TCR-pMHC docking [90]. 
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Phage library selection was performed with addition of competitor, which serves two 
purposes. In addition to being a way of selecting for increased off-rate, by removing fast-
dissociating phages and thus leaving behind binders of higher dissociation rate [101], it is also 
a way to functional elute phages. Different parameters, like incubation time and 
concentrations of antigen and phage, may be adjusted to elute clones with desired affinities 
[102]. However, very long incubation times may be required to elute high affinity binders, 
and thus other strategies may be more convenient. Hence, 100 mM TEA solution at pH 11 
was used to elute phages that remained bound after incubation with competitor. This step was 
modified from standard protocols by extending the incubation time to increase the change of 
retrieving potential high affinity clones [103].   
 
In the selection strategy used, both eluates resulting from competitive elution and from elution 
with high pH were used to infect E.coli for amplification and amplification. The competitor 
eluate (E2) is expected to include a high portion of phages displaying functional scTCRs, 
however with moderate off-rates. Clones of higher affinities in the picomolar range are 
expected to be in the TEA eluate (E3), but together with more background clones that are 
released simultaneously. 
 
The scTCR phage libraries were monitored for presence of scTCR s380 clones and human 
scFv clones with kappa light chain using PCR. Despite continued precaution, scFv-encoding 
phagemid was detected in three of eight libraries after the second round of selection. Effort 
was made to limit the propagation of the scFv-encoding phagemid by pre-selecting the phage 
libraries on pL. Nevertheless, the occurrence of scFv-encoding phagemid increased with 
every round. Fast-growing sequences, called parasite clones, can have 1000x enrichment 
during amplification in E. coli [104]. Escape of a few scFv clones in negative selection may 
thus be sufficient for subsequent retrieval in positive selection and propagation. The scTCR-
encoding phagemids were also detected in the libraries however, and thus the scFv displaying 
phages had not overgrown the cultures.  
 
Enrichment of target specific clone or clones was found in 12 of the 22 sublibraries. These 12 
libraries were positive for both the scTCR-encoding phagemid and the scFv-encoding 
phagemid in the PCR. Nine of the sub-libraries that showed positive enrichment were also 
positive for binding to the relevant target in ELISA after M13K07 rescue, while the last three 
were negative. The assumption that target specific scFv binders caused the positive signals 
 56 
obtained in the ELISA performed with the M13K07-rescued phage libraries is supported by 
the great reduction or total loss of signal when the same libraries were tested for binding after 
DeltaPhage rescue. Rescue of pIX-scTCR-encoding phagemid with DeltaPhage is expected to 
result in production of phage with high valence display of the scTCR, which in turn is 
expected to amplify the signal in ELISA due to avidity effects [21]. This was not observed 
however. 
 
When rescue of pIII-scFv-encoding phagemid was performed with DeltaPhage, relatively low 
end titers were achieved. This aspect could possibly be exploited to limit proliferation of 
scFv-displaying phages during the amplification step. However, this would result in high 
valence display of the scTCR, which is not favorable in affinity selection.  
 
Furthermore, when rescued with M13K07, a higher portion of the CDR3β libraries showed 
preferential binding to DQ2.5-glia-α1a in ELISA than the CDR3α libraries. In the context of 
the newly reported crystal structures [90], this is an interesting finding. For the CDR3β loop 
of DQ2.5-glia-α2 restricted TCRs that express the TRVB7-2 gene segment, a semi-conserved 
sequence, including a highly conserve arginine, is observed. This conservation suggests an 
important role of the CDR3β loop in mediating binding to the HLA molecule, and thus 
mutations in this loop could potentially lead to the loss of binding ability. Indeed, the CDR3β 
loop may be more sensitive to sequence alterations than the CDR3α loop, and thus library 
generation by randomization of the CDR3β loop could lead to a greater portion of non-
functional clones, and furthermore easier access of the scFv clone, compared to CDRα phage 
libraries.  
 
Single clone screening was conduced in small cultures in 96 deep well plates. Based on 
results obtained in the research group, high valence display of the fusion protein is considered 
necessary to uncover binders in this type of screening assay. Even a clone with relatively high 
monomeric affinity has proved hard to detect when displayed on pIX at low valence 
(unpublished, Nilssen, N. R. et al.). Screening of two L3 sublibraries identified two potential 
candidate clones, one from each sublibrary, which revealed by sequencing was the scFv 
clone. However, sequencing also revealed that scTCR clones were present in the clone 
population, as indicated by the PCR analysis. The assay is known to give false positives and 
negatives and, as observed repeated times by other group members (unpublished), the signal 
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strengths of one unique clone may vary greatly, even in the same experiment. Thus, repeating 
the screening could lead to other candidate clones.  
 
The specificity of the scFv clone partly explains how the clone was selected in parallel with 
the scTCR clones during selection, but characterization of the scFv clone revealed a relatively 
low affinity for DQ2.5-glia-α1a (unpublished, Høydahl, L.S.). However, unlike the scTCR 
that was displayed on pIX, the scFv clone was displayed on pIII and fusion proteins are 
displayed at higher frequency on pIII than on pIX when rescue is performed with M13K07 
[21, 105]. Thus avidity effects, caused by heterogeneous oligovalent display on pIII, provide 
further explanation for the efficient retrieval of scFv-displaying phage during selection. 
 
Growth bias arises during the amplification step between selection rounds, because different 
sequences amplify in bacteria at different rates [104]. Small differences in sequence can have 
large impact on the bacterial host viability and hence on the amplification. There are evident 
differences between TCRs and antibodies when it comes to expression of these proteins as 
recombinant molecules in E.coli. Compared to scTCR, scFv is typically much more amenable 
to production, both as soluble molecules and as fusion proteins on phage [42], and thus 
appears to be less toxic to the host. On top of this, the scFv clone was derived from a refined 
scFv phage library, which featured particularly high scFv expression and display levels [97]. 
Together, these factors result in considerable advantages for the scFv over the scTCR, and 
hence provide an explanation for the outcome of scTCR phage library selection.  
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6. Future perspectives 
 
The outcome of an affinity selection is dependent on numerous factors, including the quality 
of the start-up libraries and the selection conditions used. Libraries comprising high diversity 
are more likely to result in retrieval of high affinity ligands compared to libraries with lower 
diversity [15].   
 
A PCR protocol was established to detect scFv-encoding and scTCR-encoding phagemids in 
phage library samples. This enabled us to monitor their presence throughout the selection and 
observe that scTCR-encoding phagemid remained despite the contamination by scFv-
encoding phagemid. Furthermore, a pre-selection step on pL was design to counteract scFv 
propagation. 
  
Both the scTCR and the scFv encoding phagemids harbored the same antibiotic resistance 
gene. By cloning the scTCR-encoding cassette into a phagemid that contain a 
chloramphenicol resistance-encoding gene, which is available in our lab, one could to 
distinguish between the two phagemids and hence alleviate the scFv.  
 
The scTCR s380 phage libraries used in the selection have some weaknesses that could be 
improved to increase the chance of succeeding in isolating high affinity scTCRs. Hence, the 
phage libraries comprised 40% TAA template background due to limited mutagenesis 
efficiency. In new libraries, a highly specialized template, which upon randomization is 
forced to make a palindrome cryptic RE site due to hairpin formation, may be exploited to 
remove the template after library mutagenesis [106]. Moreover, the mutagenic efficiency 
could be increased to approx. 80% with optimal conditions and a modified Kunkel protocol, 
which has resulted in 100% mutagenized libraries, could be used [107]. Members of the 
research group are presently working to optimize library construction (unpublished).  
 
In addition, the phage phenotype-genotype linkage was disrupted when the DNA library 
transformation was conducted with high phagemid to cell ratio, which caused 20-30% of the 
E.coli population to contain more than one phagemid. This could be avoided by 
electroporation of smaller amounts of library DNA.  
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The selection conditions used in the affinity selection were modified throughout the process 
as new information was obtained, and thus several parameters have been optimized for our 
system, including the washing step and elution conditions. The same selection strategy would 
be applied in a new attempt to affinity mature the scTCR, preferably in parallel with selection 
conducted without off-rate selection, as different strategies tend to select different clones. 
 
Identification of TCR candidate clones would need further validation, including investigation 
of expression yield in soluble form, and testing of binding specificity and affinity by surface 
plasmon resonance. Furthermore, independent mutations in the CDR3α and CDR3β could be 
combined to yield much higher affinities. 
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7. Supplementary results  
7.1 Supplementary 1 
 
Construction, selection and screening of CDR3α and CDR3β scTCR libraries performed by 
Lene Støkken Høydahl 
 
Overview: 
- CDR3α and CDR3β mutagenesis and library packaging 
- Selection and polyclonal ELISA 
- Illumina sequencing 
- Library analysis by sequencing – library quality 
 
CDR3α and CDR3β mutagenesis and library packaging 
	  
Assuming conventional TCR docking onto pMHC, the CDR3 loops of the TCR should 
primarily contact the peptide. These loops were therefore chosen for affinity maturation by 
random mutagenesis using a modified Kunkel mutagenesis protocol adapted from Siddhu and 
Tonikian et al [14, 108]. Briefly, by using uracil-containing ssDNA as template for library 
generation by complementary strand synthesis using degenerate primers, followed by E. coli 
SS320 electroporation, the uracil-containing template should be degraded. However, as the 
mutagenesis frequency is not 100% and not all template DNA will be degraded in E. coli, a 
TAA stop codon was inserted into CDR3α and CDR3β of the template by QuikChange 
mutagenesis (oligos in Table 9) to ensure that remaining template background would be 
rendered non-functional. Mutagenesis was done using templates both with and without FkpA-
encoding gene to see if chaperone co-expression influence in the selection process. Various 
oligos were used to target different parts of the CDR3 loops (Table 8, Table 10).   	  
 
 
Figure 16: CDR3α and CDR3β loops of TCR 380. CDR3α and CDR3β loop amino acid sequences are 
shown according to IMGT loop definition. Bold; residues actually forming the loop. Underlined; 
residues replaced by TAA stop codon. 
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Table 8: Mutagenic oligos for randomization of the CDR3α	  and	  CDR3β	  loops 
CDR3α oligos  
Oligo name Sequencea Teoretical diversity Mutagenesis strategyb 
Oligo 1 N-DHYSSGSARQ-C 6-mer (6.40x 107) NNK 
Oligo 2 N-DHYSSGSARQ-C 7-mer (1.28x 109) NNK 
Oligo 3 N-DHYSSGSARQ-C 6-mer (6.40x 107) NNK 
Oligo 4 N-DHYSSGSARQ-C 7-mer (1.28x 109) NNK 
Oligo 5 N-DHYSSGSARQ-C 6-mer (1.77x 106) NWW 
Oligo 6 N-DHYSSGSARQ-C 7-mer (1.28x 109)  NNK+fixed 
Oligo 7b N-DHYSSARQ-C  6-mer (6.40x 107) NNK 
CDR3β oligos 
Oligo name Sequencea Theoretical diversity Mutagenesis strategyb 
Oligo 8 N-TAVLAGGP-C  6-mer (6.40x 107)  NNK 
Oligo 9 N-TAVLAGGP-C  6-mer (6.40x 107) NNK 
Oligo 10 N-TAVLAGGP-C 6-mer (6.40x 107) NNK 
Oligo 11 N-TAVLAGGP-C  6-mer (1.77x 106) NWW 
Oligo 12 N-TAVLAGGP-C  7-mer (1.28x 109) NNK 
Oligo 13 N-TAVLAGGP-C  6-mer (6.40x 107) NNK+fixed 
a Underlined; residues targeted by oligo, b Degenerate codons, N ! any nucleotide, K ! T or G, NNK! any amino acid, NWW ! 
hydrophobic or charged amino acids 
b Shortens loops with two amino acids 	  
 
Sublibraries representing each oligo were made separately on DNA level, but to reduce the 
number of E. coli SS320 aliquots needed for transformation, DNA libraries made from 
CDR3α 6-mers or CDR3β 6-mers were mixed before electroporation, while 7-mers were kept 
separate. Electroporated E. coli SS320 was grown in culture 30min, before each culture was 
split in two. Phagemid rescue was performed by addition of helper phage (as described in 
3.3.2), either M13K07 or DeltaPhage, to package all libraries with low or high valence 
display of the scTCR fusion.  
 
Before the initial culture was split, each electroporated library was titrated as described in 
3.2.3 to determine library size. A CDR3α library size of 1.80x1010 individual transformants 
was obtained, 4.47 times higher than the theoretical diversity of 4.03x109 individual clones. 
Obtained CDR3β library size was 1.13x1010 individual transformants, 7.34 times higher than 
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the theoretical diversity of 1.54x109 individual clones. For all sublibraries electroporated, the 
obtained number of transformants covered the theoretical sizes of each library (results not 
shown). 
 
Table 9: Oligos to introduce stop codon in the CDR3α	  and	  CDR3β	  loops 
Oligo name Oligo sequence 
Q_CDR3alphaSTOP_fw 5’- CTGTGCTCTGAGTGATCACTATTAATCTGGTTCTGCAAGGCAACCTGACC-3’  
Q_CDR3alphaSTOP_rv 5’- GGTCAGGTTGCCTTGCAGAACCAGATTAATAGTGATCACTCAGAGCACAG-3’ 
Q_CDR3betaSTOP_fw 5’- CCAGCAGCACAGCGTAACTAGCGGGAGGGCCG-3’ 
Q_CDR3betaSTOP_rv 5’- CGGCCCTCCCGCTAGTTACGCTGTGCTGCTGG-3’ 
 
 
Table 10: Mutagenic oligos for randomization of the CDR3α	  and	  CDR3β	  loops at DNA level 
Oligo name Oligo sequencea 
CDR3α oligos 
Oligo 1 5’-TTC TGT GCT CTG AGT NNK NNK NNK NNK NNK NNK TCT GCA AGG CAA CTG-3’ 
Oligo 2 5’-CTG AGT GAT CAC TAT NNK NNK NNK NNK NNK NNK NNK CTG ACC TTT GGA TCT-3’ 
Oligo 3 5’-GCT CTG AGT GAT CAC NNK NNK NNK NNK NNK NNK AGG CAA CTG ACC TTT-3’ 
Oligo 4 5’-TGT GCT CTG AGT GAT NNK NNK NNK NNK NNK NNK NNK AGG CAA CTG ACC TTT-3’ 
Oligo 5 5’- GCT CTG AGT GAT CAC NWW NWW NWW NWW NWW NWW AGG CAA CTG ACC TTT-3’ 
Oligo 6 5’- TGT GCT CTG AGT GAT NNK TAT NNK NNK NNK NNK NNK NNK AAA CTG ACC TTT GGA TCT-3’ 
Oligo 7 5’-TGT GCT CTG AGT GAT NNK NNK NNK NNK NNK NNK CAA CTG ACC TTT GGA-3’ 
CDR3β oligos: 
Oligo 8 5’-CTC TGT GCC AGC AGC NNK NNK NNK NNK NNK NNK GGG CCG CAG TAC TTC-3’ 
Oligo 9 5’-GCC AGC AGC ACA GCG NNK NNK NNK NNK NNK NNK CAG TAC TTC GGG CCG-3’ 
Oligo 10 5’- TGT GCC AGC AGC ACA NNK NNK NNK NNK NNK NNK CCG CAG TAC TTC GGG-3’ 
Oligo 11 5’- TGT GCC AGC AGC ACA NWW NWW NWW NWW NWW NWW CCG CAG TAC TTC GGG-3’ 
Oligo 12 5’- TGT GCC AGC AGC ACA NNK NNK NNK NNK NNK NNK NNK CAG TAC TTC GGG CCG -3’ 
Oligo 13 5’- CTC TGT GCC AGC AGC CTG NNK NNK NNK NNK NNK NNK GAA CAG TAC TTC GGG CCG-3’ 
a Degenerate codons, N ! any nucleotide, K ! T or G, NNK! any amino acid, NWW ! hydrophobic or charged amino acids 
 
 
Selection and polyclonal ELISA 	  
Phages from CDR3α and CDR3β phage sublibraries were pooled before selection, resulting in 
the following libraries selected in R1. 
 
L1. scTCR s380 CDR3α/scTCR s380 CDR3β – M13K07 rescue 
L2. scTCR s380 CDR3α/scTCR s380 CDR3β – Deltaphage rescue 
L3. scTCR s380 CDR3α FkpA/scTCR s380 CDR3β FkpA – M13K07 rescue 
L4. scTCR s380 CDR3α FkpA/scTCR s380 CDR3β FkpA – Deltaphage rescue 
 
In R1 the 4 libraries, L1-L4, were selected as described in 3.3.2. In R2 and R3, each of the 4 
libraries was selected in parallel using two different selection strategies, with (alternative 1, 
A1) or without (alternative 2, A2) competitor in solution. After R1-R3, polyclonal ELISA was 
performed as described in 3.4.2 (Figure 17).  
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Figure 17: Polyclonal ELISA of phage libraries from selection R2 (A) and R3 (B). Binding of the 
phage libraries to DQ2.5-glia-α1a and DQ2.5-CLIP2 is shown. The experiment was performed in 
duplicate and the mean ±sd is shown. 
 
Illumina sequencing 	  
Encouraged by the results from polyclonal ELISA, CDR3 loops regions were amplified by 
PCR and sequenced by Illumina (Norwegian Sequencing Centre). Single clones expression 
and binding analysis is labor intensive and well known for false positives and negatives. In 
addition, it is usually necessary to screen a high number of clones. Using a high-throughput 
sequencing platform, such as Illumina sequencing, up to 1.6x108 reads with read lengths of 
100-150 nucleotides are obtained. Several papers have employed high-throughput sequencing 
technologies combined with selection. In line with this, Ravn et al. compared Illumina 
sequencing with classical screening. Based on sequence frequency after Illumina sequencing, 
they retrieved the most potent clone and valuable candidates that were not identified with 
classical screening (Ravn, U., et al., 2010). 
 
The results showed that the diversity of the library was still high, and no clear enrichment of 
any sequences could be found. Surprisingly, a high percentage of the library was the template 
used to generate the libraries, representing between 10-30% of the sequences. In order to 
decrease the diversity and to enrich for specific binders, it was decided that two additional 
round of selection would be performed on the libraries.  	   	  	  
  
A B 
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7.2 Supplementary 2  
 
Selection R4 and R5 and screening performed by Jeannette Nilsen 
 
Overview: 
 
- Selection and polyclonal ELISA 
- Bacth-cloning from phagemid to pFKPEN-vector 
- Screening of soluble scTCR from small scale expression 
 
Selection and polyclonal ELISA 
 
Eight phage libraries, L1-L8, were selected a fourth (R4) and a fifth round (R5). These 
selection rounds were performed essentially as in R3 (supplementary 1), using the two 
strategies, with and without competitor in solution for L1-L4 and L5-L8, respectively. After 
R4-R5, polyclonal ELISA was performed as described in 3.4.2, with the exception that the 
phage library input was normalized and 1x1011 virions/well was used. 
 
 
Figure 18: Polyclonal ELISA of phage libraries from selection R4 (A) and R5 (B). Binding of the 
phage libraries to DQ2.5-glia-α1a and DQ2.5-CLIP2 is shown. The experiment was performed in 
duplicate and the mean ±sd is shown. 
 
Increased signals from R2-R5 indicated enrichment of target specific binders. 
 
  
Batch-cloning from phagemid to pFKPEN-vector for soluble expression of scTCR 
 
Phagemids in library L7 after the fifth round of panning were isolated, from E.coli that had 
been infected with the library output and plated onto solid media on Q-trays (described in 
3.3.3), using miniprep as described in 3.5.1. The scTCR-encoding cassettes were isolated 
A B 
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using Nco I and Not I (NEB) restriction sites and batch-cloned into the expression vector 
pFKPEN. The pFKPEN-vector is a derivate of the pHOG-dummy described previously [97], 
which contains the FkpA-encoding gene that is controlled by its native promoter [45].  
 
The isolated phagemids were digested using the restriction enzymes Nco l and Not I (NEB), 
followed by separation of the products by gel electrophoresis (described in 3.5.2). The bands 
corresponding to the scTCR cassettes were isolated from the gel and purified using QIAquick 
Gel extraction kit (Qiagen). pFKPEN-phox vector was digested with the same restriction 
enzymes and treated with calf intestinal alkaline phosphatase (CIP).  
 
The scTCR cassettes were ligated into the pFKPEN expression vectors with an insert:vector 
ratio of 3:1. In addition, the ligation mixture was also prepared without insert, to monitor the 
vector background. The ligation mixtures were transformed into approx. 40 µl 
electrocompetent XL1-blue cells (stratagene). Electroporation was performed at 1.3V and the 
cells were plated onto LA-amp dishes for ON incubation at 37°C. The transformation resulted 
in high number of transformants and low vector background of approx. 2.85%. 
 
Small-scale expression of soluble scTCR and screening 
 
186 single clones was from L7 were expanded in 400 µl expression cultures, separated into 
the medium and periplasmic fractions as described in [46], and tested for binding to in ELISA 
as described in 3.4.3.  No binders to DQ2.5-glia-α1a were found. 18 single clones were 
sequenced as described in 3.5.3, and sequencing revealed that the clones were not scTCRs, 
however they were scFv clones of varying sequences.  
 
In parallel with scTCR phage library selection R1-R3, a scFv-pIII phage library was selected 
against the same target, DQ2.5-glia-α1a. This selection identified three DQ2.5-glia-α1a 
specific clones (Høydahl, unpublished).  
 
Thus, these intersecting panning campaigns had lead to contamination of the scTCR s380 
phage libraries with various DQ2.5-glia-α1a specific scFv clones. 
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7.3 Supplementary 3 
 
Analysis of initial phage libraries (R0) by PCR 
 
 
	  
	   	  	  
Figure 19: Gel electrophoresis showing the result of PCR analysis of the initial phage libraries. Two 
and two wells are marked according to the library template that was used. The first and the second 
well correspond to the PCRs performed with primer set specific for scTCR s380- and scFv-encoding 
phagemid, respectively. Six controls were included in the PCRs and are shown. 100 bp DNA ladder 
was included in all gels and the relevant fragments are marked. 
 
The initial phage libraries were screened for presence of phagemid harboring scTCR S380 
and phagemid harboring human scFv with kappa light chain by PCR (described in 3.4.1). 
Clear bands of expected size of about 500bp were obtained using the scTCR primer set 
(Figure 19), indicating presence of scTCR s380 phagemid. With the scFv primer-set no bands 
of expected size were obtained for any of the library samples, indicating that scFv phagemid 
was not present.  
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7.4 Supplementary 4 
 
Titration 
 
Phagemids are introduced to E. coli for amplification and subsequent super infection with 
helper phage is required for phage production. Two kinds of helper phages were prepared 
(described in 3.2.1), and in order to use the appropriate amount in phagemid rescue, the virion 
concentration was estimated by spot titration (described in 3.2.2) and by optical density at 
A268nm [14]. The titer based on A268nm was obtained using the following calculation: A268nm x 
2.5x1012 = X virions/ml, which is modified from [14] based on the size difference to the 
phGHam-g8 phagemid.  
 
 
Figure 20: End titers of M13K07 and DeltaPhage after amplification and PEG precipitation. 
 
The helper phage preparations were not made simultaneously. A slightly higher OD titer that 
infection titer normally observed [93]. This is also seen for the M13K07 preparations, in 
which case approx. 3x1011 cfukan/ml and 9x1011 v/ml were determined with spot and OD 
titration, respectively (Figure 20). For the DeltaPhage preparations, however, the opposite is 
observed. By spot titration, the titer was estimated to be more than three and ten times higher 
than by OD titration, for preparation numbered 1 and 2, respectively. Thus, indicating 
overestimated infection titers. The OD titers were used in down stream experiments.  
 
Agarose gel electrophoresis analysis   
 
Polyphage can be produced during phage packaging [109] and may interfere with phagemid 
rescue if present in large quantities. Gel electrophoresis was performed on 25 µl	  helper phage 
preparations. The phage samples were mixed with 5 µl 6x sample buffer and added to the 
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wells of a stain-free 1%w/v agarose gel. The sample content was separated at 60V/3h in 
1xTAE buffer using power pac 300 (Biorad, CA, USA). The virion capsids were denatured by 
incubating the gel in 200 ml 0.2 M NaOH for 1h, which was further rinsed in 100 ml dH2O 
for 5 min and incubated in 100 ml 1 M Tris-HCl, pH 7 for 15 min. The ssDNA genomes in 
the gel were stained by further incubation for 1h in 100 ml dH2O with SYBR safe DNA gel 
stain (1:10000) (Life technologies) and then visualized using Gel DocTM EZ Imager (Biorad) 
(Figure 21).  
 
  
 
Figure 21: Agarose gel electrophoresis analysis of M13K07	  (A)	  and	  DeltaPhage	  (B)	  preparations.	  
The theoretical genome sizes for M13K07 and DeltaPhage are 8669 bp and 8678 bp, respectively. 1kB 
ladder was included in both gels. 
 
For all preparations only minor fractions appeared to be of multi-length phage genomes 
(polyphage) as normally seen in any helper phage system. The genome sizes of the two helper 
phages differ only by nine bp, and thus would normally migrate to the same point on the gel. 
However, the preparations were not run on the same gel, which may explain the disparity.  
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7.5 Supplementary 5 
 
Determining the growth curve of E. coli SS320 
 
After a selection round, E. coli are transduced with the eluted phages to enable library 
amplification. The ratio between E. coli and phage is of importance to get full recovery of 
library members and to maintain genotype-phenotype link. Furthermore, superinfection with 
helper phage is done at MOI 20 to ensure rescue of all library clones (described in 3.3.3). In 
order to determine the relationship between absorbance and the number of cells/ml, the 
growth curve of E. coli SS320 was monitored.  
 
E.coli SS320 cells were inoculated in 2x YT supplemented with 30 µg/ml tet and incubated 
with shaking at 220rpm/37°C/ON. SS320 cells were re-inoculated to OD600nm 0.025 in 100 ml 
2x YT supplemented with 30 µg/ml tet and incubated with shaking at 220rpm/37°C using SI-
600R incubator (Lab companion). 1 ml of the culture was removed every 20 min for 5 h and 
the absorbance was measured at 600nm using spectrophotometer WPA SL05 (Biochrom, 
Cambridge, UK). Each time the absorbance was measured, a dilution series was prepared for 
the culture in 2x YT according to Table 2. 3µl of each dilution was spotted onto a BA85/20 
nitrocellulose membrane (Whatman) that was laid on top of LB-agar dishes. The dishes were 
incubated at 37°C/ON. The number of cfu/ml present in the original culture was calculated 
using the formula (cfu x dilution-1 x 1000)/3. The growth curve was made by plotting LOG 
(cfu/ml) as function of OD600nm and by performing linear regression in Prism 6 (GraphPad, 
CA, USA). 
 
 
 
Figure 22: E. coli SS320 growth curve presented in a semi-log graph 
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From the regression equation, the number of cells per ml in a culture when OD600nm is 0.1 was 
calculated to be approx. 4x108 cells/ml. This knowledge was used to determine the culture 
size needed to exceed the number of eluted phage after a selection round. A 10 ml SS320 
culture at OD600nm 0.5 was estimated to comprise a large surplus of E. coli compared to the 
output size that are expected from selection. The number of helper phage needed for rescue at 
MOI20 was also calculated. 	  
7.6 Supplementary 6 
 
Evaluation of phage elution with TEA 
 
Exposure to a high pH solution, such as 100 mM TEA at pH 11, is a commonly used strategy 
to elute binders after selection. Short incubation time of 5-10 min is adequate to release the 
majority of the phages, but high-affinity binders may still be bound to the antigen and thus 
longer incubation time might be required [103]. However, high pH can influence protein 
structure by altering electrostatic interactions between amino acids. To investigate if prolong 
incubation at high pH could have a negative effect on phage infectivity, phages were 
incubated with 100 mM TEA pH 11 for various time periods before neutralization and then 
titrated using spot titration (described in 3.2.2).  
 
Equal aliquots of M13K07-rescued phages displaying wild type (wt) scTCR s380 on pIX 
were transferred to seven 1.5 ml tubes. 500 µl 0.1 M triethylamine (TEA) pH 11 (Sigma) was 
added to six of the phage-containing tubes and these were incubated on a SB3 rotator (Stuart, 
Staffordshire, UK) in RT for 5, 10, 15, 20, 25 and 30 minutes, before neutralization with 500 
µl 1 M Tris-HCl pH 7.5. Each TEA treated phage sample was spot titrated as described in 
3.2.2. The graph was made by plotting the number of infectious particles (given as cfuamp)/ml 
as a function of time using Prism 6 (GraphPad).  
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Figure 23: Evaluation of the elution conditions when using TEA at pH 11. The number of infectious 
particles is shown as a function of incubation time. The titers are given as amp resistant colony 
forming units (cfuamp) per ml. Two independent experiments are shown.  
 
The results showed that the infectivity is not negatively influenced by prolonged exposure to 
high pH (Figure 23). Thus to increase the chance of retrieving potential high affinity clones, 
the selection protocol was modified and selected phages were eluted by treatment with TEA 
pH 11 for 20 minutes. 
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